| Year |
Citation |
Score |
| 2022 |
Brierley SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, Storr M, Tack J. Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome. Nature Reviews. Gastroenterology & Hepatology. PMID 36168049 DOI: 10.1038/s41575-022-00682-y |
0.437 |
|
| 2020 |
Szymaszkiewicz A, Włodarczyk J, Wasilewski A, Di Marzo V, Storr M, Fichna J, Zielińska M. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 32002574 DOI: 10.1007/S00210-020-01829-X |
0.33 |
|
| 2020 |
Kienzl M, Storr M, Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clinical and Translational Gastroenterology. PMID 31899693 DOI: 10.14309/Ctg.0000000000000120 |
0.33 |
|
| 2019 |
Fabisiak A, Włodarczyk M, Fabisiak N, Storr M, Fichna J. Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal and Liver Diseases : Jgld. 28: 473-481. PMID 31826058 DOI: 10.15403/Jgld-265 |
0.356 |
|
| 2019 |
Salaga M, Binienda A, Tichkule RB, Thakur GA, Makriyannis A, Storr M, Fichna J. Corrigendum to "The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome" [Eur. J. Pharmacol. (2018), 836 34-43]. European Journal of Pharmacology. 172656. PMID 31519354 DOI: 10.1016/J.Ejphar.2019.172656 |
0.337 |
|
| 2019 |
Szymaszkiewicz A, Malkiewicz A, Storr M, Fichna J, Zielinska M. The place of tachykinin NK2 receptor antagonists in the treatment diarrhea-predominant irritable bowel syndrome. Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society. 70. PMID 31019119 DOI: 10.26402/Jpp.2019.1.01 |
0.332 |
|
| 2018 |
Szymaszkiewicz A, Storr M, Fichna J, Zielinska M. Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. e13526. PMID 30549162 DOI: 10.1111/Nmo.13526 |
0.337 |
|
| 2018 |
Salaga M, Binienda A, Tichkule RB, Thakur GA, Makriyannis A, Storr M, Fichna J. The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. European Journal of Pharmacology. PMID 30121173 DOI: 10.1016/J.Ejphar.2018.08.016 |
0.357 |
|
| 2018 |
Szymaszkiewicz A, Zielinska M, Li K, Ramanathan M, Alam S, Hou DR, Fichna J, Storr M. Novel derivatives of 1,2,3-triazole, cannabinoid-1 receptor ligands modulate gastrointestinal motility in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 29404698 DOI: 10.1007/S00210-018-1465-9 |
0.308 |
|
| 2017 |
Binienda A, Storr M, Fichna J, Salaga M. Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review. Current Drug Targets. PMID 29284389 DOI: 10.2174/1389450119666171227225408 |
0.355 |
|
| 2017 |
Salaga M, Zatorski H, Zielińska M, Mosinska P, Timmermans JP, Kordek R, Storr M, Fichna J. Highly selective CB receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 390: 1015-1027. PMID 28710683 DOI: 10.1007/S00210-017-1402-3 |
0.34 |
|
| 2017 |
Bashashati M, Fichna J, Piscitelli F, Capasso R, Izzo AA, Sibaev A, Timmermans JP, Cenac N, Vergnolle N, Di Marzo V, Storr M. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT). Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 29. PMID 28695708 DOI: 10.1111/Nmo.13148 |
0.325 |
|
| 2017 |
Fabisiak A, Włodarczyk J, Fabisiak N, Storr M, Fichna J. Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. Journal of Neurogastroenterology and Motility. PMID 28551943 DOI: 10.5056/Jnm16203 |
0.342 |
|
| 2017 |
Wasilewski A, Lewandowska U, Mosinska P, Watala C, Storr M, Fichna J, Venkatesan T. Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome. The American Journal of Gastroenterology. PMID 28349993 DOI: 10.1038/Ajg.2017.73 |
0.305 |
|
| 2017 |
Hasenoehrl C, Storr M, Schicho R. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? Expert Review of Gastroenterology & Hepatology. 11: 329-337. PMID 28276820 DOI: 10.1080/17474124.2017.1292851 |
0.341 |
|
| 2017 |
Mosińska P, Zatorski H, Storr M, Fichna J. Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists. Journal of Neurogastroenterology and Motility. PMID 28238253 DOI: 10.5056/Jnm16183 |
0.333 |
|
| 2017 |
Zielińska M, Fichna J, Bashashati M, Habibi S, Sibaev A, Timmermans JP, Storr M. G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 29. PMID 28191706 DOI: 10.1111/Nmo.13025 |
0.336 |
|
| 2017 |
Taschler U, Hasenoehrl C, Storr M, Schicho R. Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance. Handbook of Experimental Pharmacology. PMID 28161834 DOI: 10.1007/164_2016_105 |
0.381 |
|
| 2016 |
Hasenoehrl C, Taschler U, Storr M, Schicho R. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 28: 1765-1780. PMID 27561826 DOI: 10.1111/Nmo.12931 |
0.36 |
|
| 2016 |
Jarmuż A, Banaszek M, Leń K, Storr M, Zielińska M, Fichna J. The role of MOP and DOP receptors in treatment of diarrhea-predominant irritable bowel syndrome. Mini Reviews in Medicinal Chemistry. PMID 27494159 DOI: 10.2174/1389557516666160804165318 |
0.346 |
|
| 2016 |
Krohn RM, Parsons SA, Fichna J, Patel KD, Yates RM, Sharkey KA, Storr MA. Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment. Journal of Inflammation (London, England). 13: 21. PMID 27418880 DOI: 10.1186/S12950-016-0129-0 |
0.441 |
|
| 2016 |
Sobolewska-Włodarczyk A, Włodarczyk M, Storr M, Fichna J. Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. Therapeutics and Clinical Risk Management. 12: 771-5. PMID 27257381 DOI: 10.2147/Tcrm.S83722 |
0.331 |
|
| 2016 |
Zielińska M, Jarmuż A, Sałaga M, Kordek R, Laudon M, Storr M, Fichna J. Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 26899972 DOI: 10.1007/S00210-016-1214-X |
0.318 |
|
| 2016 |
Salaga M, Storr M, Martemyanov KA, Fichna J. RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. PMID 26817719 DOI: 10.1002/Bies.201500118 |
0.304 |
|
| 2015 |
Abalo R, Chen C, Vera G, Fichna J, Thakur GA, López-Pérez AE, Makriyannis A, Martín-Fontelles MI, Storr M. In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. PMID 26387676 DOI: 10.1111/Nmo.12668 |
0.33 |
|
| 2015 |
Fichna J, Poole DP, Veldhuis N, MacEachern SJ, Saur D, Zakrzewski PK, Cygankiewicz AI, Mokrowiecka A, Małecka-Panas E, Krajewska WM, Liedtke W, Steinhoff MS, Timmermans JP, Bunnett NW, Sharkey KA, ... Storr MA, et al. Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission. Journal of Molecular Medicine (Berlin, Germany). PMID 26330151 DOI: 10.1007/s00109-015-1336-5 |
0.486 |
|
| 2015 |
Zoller V, Laguna AL, Prazeres Da Costa O, Buch T, Göke B, Storr M. [Fecal microbiota transfer (FMT) in a patient with refractory irritable bowel syndrome]. Deutsche Medizinische Wochenschrift (1946). 140: 1232-6. PMID 26261935 DOI: 10.1055/S-0041-103798 |
0.31 |
|
| 2015 |
Sibaev A, Fichna J, Saur D, Yuece B, Timmermans JP, Storr M. Nociceptin effect on intestinal motility depends on opioid-receptor like-1 receptors and nitric oxide synthase co-localization. World Journal of Gastrointestinal Pharmacology and Therapeutics. 6: 73-83. PMID 26261735 DOI: 10.4292/Wjgpt.V6.I3.73 |
0.326 |
|
| 2015 |
Stančić A, Jandl K, Hasenöhrl C, Reichmann F, Marsche G, Schuligoi R, Heinemann A, Storr M, Schicho R. The GPR55 antagonist CID16020046 protects against intestinal inflammation. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 27: 1432-45. PMID 26227635 DOI: 10.1111/Nmo.12639 |
0.359 |
|
| 2015 |
Taschler U, Eichmann TO, Radner FP, Grabner GF, Wolinski H, Storr M, Lass A, Schicho R, Zimmermann R. Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity. British Journal of Pharmacology. 172: 4419-29. PMID 26075589 DOI: 10.1111/Bph.13224 |
0.376 |
|
| 2015 |
Jarmuż A, Zielińska M, Storr M, Fichna J. Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 27: 1057-68. PMID 25930667 DOI: 10.1111/Nmo.12574 |
0.348 |
|
| 2015 |
Wasilewski A, Zieli?ska M, Storr M, Fichna J. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 21: 1674-82. PMID 25822014 DOI: 10.1097/Mib.0000000000000364 |
0.325 |
|
| 2015 |
Bashashati M, Nasser Y, Keenan CM, Ho W, Piscitelli F, Nalli M, Mackie K, Storr MA, Di Marzo V, Sharkey KA. Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. British Journal of Pharmacology. 172: 3099-111. PMID 25684407 DOI: 10.1111/Bph.13114 |
0.408 |
|
| 2015 |
Keenan CM, Storr MA, Thakur GA, Wood JT, Wager-Miller J, Straiker A, Eno MR, Nikas SP, Bashashati M, Hu H, Mackie K, Makriyannis A, Sharkey KA. AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner. British Journal of Pharmacology. 172: 2406-18. PMID 25572435 DOI: 10.1111/Bph.13069 |
0.444 |
|
| 2015 |
Wasilewski A, Storr M, Zieli?ska M, Fichna J. Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases. Inflammatory Bowel Diseases. 21: 666-73. PMID 25461621 DOI: 10.1097/Mib.0000000000000258 |
0.35 |
|
| 2014 |
Fichna J, Bawa M, Thakur GA, Tichkule R, Makriyannis A, McCafferty DM, Sharkey KA, Storr M. Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors. Plos One. 9: e109115. PMID 25275313 DOI: 10.1371/Journal.Pone.0109115 |
0.559 |
|
| 2014 |
Chen C, Yu Z, Li Y, Fichna J, Storr M. Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications. The American Journal of Chinese Medicine. 42: 1053-70. PMID 25183302 DOI: 10.1142/S0192415X14500669 |
0.314 |
|
| 2014 |
Fichna J, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Cenac N, Sa?aga M, Timmermans JP, Vergnolle N, Ma?ecka-Panas E, Krajewska WM, Storr M. Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 26: 1539-50. PMID 25041572 DOI: 10.1111/Nmo.12390 |
0.361 |
|
| 2014 |
Sibaev A, Yuece B, Allescher HD, Saur D, Storr M, Kurjak M. The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats. Pharmacological Reports : Pr. 66: 256-63. PMID 24911079 DOI: 10.1016/J.Pharep.2013.09.008 |
0.327 |
|
| 2014 |
Sa?aga M, Mokrowiecka A, Zakrzewski PK, Cygankiewicz A, Leishman E, Sobczak M, Zatorski H, Ma?ecka-Panas E, Kordek R, Storr M, Krajewska WM, Bradshaw HB, Fichna J. Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH). Journal of Crohn's & Colitis. 8: 998-1009. PMID 24530133 DOI: 10.1016/J.Crohns.2014.01.025 |
0.325 |
|
| 2014 |
Schicho R, Storr M. Cannabis finds its way into treatment of Crohn's disease. Pharmacology. 93: 1-3. PMID 24356243 DOI: 10.1159/000356512 |
0.329 |
|
| 2014 |
Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Storr M, Kordek R, Małecka-Panas E, Krajewska WM, Fichna J. Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases. The Journal of Pharmacology and Experimental Therapeutics. 348: 401-9. PMID 24345466 DOI: 10.1124/Jpet.113.209825 |
0.382 |
|
| 2014 |
Füllhase C, Campeau L, Sibaev A, Storr M, Hennenberg M, Gratzke C, Stief C, Hedlund P, Andersson KE. Bladder function in a cannabinoid receptor type 1 knockout mouse. Bju International. 113: 144-51. PMID 24053792 DOI: 10.1111/Bju.12350 |
0.304 |
|
| 2014 |
Botteselle L, Zhao X, Göke B, Sibaev A, Storr M. Su2040 Interaction Between GPR119 and CB1 Receptors in the Inhibition of Contractile Activity in Mouse and Human Gut Gastroenterology. 146: S-530. DOI: 10.1016/S0016-5085(14)61918-1 |
0.302 |
|
| 2013 |
Li YY, Cao MH, Goetz B, Chen CQ, Feng YJ, Chen CJ, Kasparek MS, Sibaev A, Storr M, Kreis ME. The dual effect of cannabinoid receptor-1 deficiency on the murine postoperative ileus. Plos One. 8: e67427. PMID 23844009 DOI: 10.1371/Journal.Pone.0067427 |
0.35 |
|
| 2013 |
Sobczak M, Sałaga M, Storr M, Fichna J. Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases. Current Drug Targets. 14: 1203-9. PMID 23773151 DOI: 10.2174/13894501113149990174 |
0.372 |
|
| 2013 |
Fichna J, Sibaev A, Sałaga M, Sobczak M, Storr M. The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 25: e550-9. PMID 23692073 DOI: 10.1111/Nmo.12158 |
0.361 |
|
| 2013 |
Li K, Fichna J, Schicho R, Saur D, Bashashati M, Mackie K, Li Y, Zimmer A, Göke B, Sharkey KA, Storr M. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology. 71: 255-63. PMID 23603203 DOI: 10.1016/J.Neuropharm.2013.03.029 |
0.55 |
|
| 2013 |
Li YY, Yuece B, Cao HM, Lin HX, Lv S, Chen JC, Ochs S, Sibaev A, Deindl E, Schaefer C, Storr M. Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 322-33. PMID 23381627 DOI: 10.1038/Labinvest.2012.177 |
0.31 |
|
| 2013 |
Ottillinger B, Storr M, Malfertheiner P, Allescher HD. STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders. Wiener Medizinische Wochenschrift (1946). 163: 65-72. PMID 23263639 DOI: 10.1007/S10354-012-0169-X |
0.3 |
|
| 2013 |
Michler T, Storr M, Kramer J, Ochs S, Malo A, Reu S, Göke B, Schäfer C. Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms. American Journal of Physiology. Gastrointestinal and Liver Physiology. 304: G181-92. PMID 23139224 DOI: 10.1152/Ajpgi.00133.2012 |
0.32 |
|
| 2013 |
Fichna J, Habibi S, Bashashati M, Storr M. Mo2098 A Novel Function for Estrogen Receptor GPR30: Control of Gastrointestinal Motility and Visceral Sensation Gastroenterology. 144: S-741-S-742. DOI: 10.1016/S0016-5085(13)62750-X |
0.319 |
|
| 2012 |
Schicho R, Storr M. A potential role for GPR55 in gastrointestinal functions. Current Opinion in Pharmacology. 12: 653-8. PMID 23063456 DOI: 10.1016/J.Coph.2012.09.009 |
0.362 |
|
| 2012 |
Bashashati M, Rezaei N, Bashashati H, Shafieyoun A, Daryani NE, Sharkey KA, Storr M. Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 24: 1102-e566. PMID 22897390 DOI: 10.1111/J.1365-2982.2012.01990.X |
0.467 |
|
| 2012 |
Schicho R, Storr M. Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice. Pharmacology. 89: 149-55. PMID 22414698 DOI: 10.1159/000336871 |
0.323 |
|
| 2012 |
Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, Jobin C, Arthur JC, Corl BA, Vogel H, Storr M, Hontecillas R. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. Plos One. 7: e31238. PMID 22363592 DOI: 10.1371/Journal.Pone.0031238 |
0.322 |
|
| 2012 |
Hons IM, Storr MA, Mackie K, Lutz B, Pittman QJ, Mawe GM, Sharkey KA. Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 24: e113-24. PMID 22235973 DOI: 10.1111/J.1365-2982.2011.01860.X |
0.423 |
|
| 2012 |
Bashashati M, Rezaei N, Andrews CN, Chen CQ, Daryani NE, Sharkey KA, Storr MA. Cytokines and irritable bowel syndrome: where do we stand? Cytokine. 57: 201-9. PMID 22178716 DOI: 10.1016/J.Cyto.2011.11.019 |
0.442 |
|
| 2012 |
Bashashati M, Storr MA, Nikas SP, Wood JT, Godlewski G, Liu J, Ho W, Keenan CM, Zhang H, Alapafuja SO, Cravatt BF, Lutz B, Mackie K, Kunos G, Patel KD, et al. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice. British Journal of Pharmacology. 165: 1556-71. PMID 21883147 DOI: 10.1111/J.1476-5381.2011.01644.X |
0.545 |
|
| 2012 |
Bashashati M, Rezaei N, Bashashati H, Shafieyoun A, Daryani NE, Sharkey KA, Storr M. Tu1427 Interleukin-10 and TGF-1 Anti-Inflammatory Cytokine Gene Polymorphisms are Involved in the Pathophysiology of Irritable Bowel Syndrome: A Meta-Analysis Gastroenterology. 142: S-830. DOI: 10.1016/S0016-5085(12)63221-1 |
0.474 |
|
| 2011 |
Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World Journal of Gastroenterology : Wjg. 17: 3888-98. PMID 22025877 DOI: 10.3748/Wjg.V17.I34.3888 |
0.373 |
|
| 2011 |
Schicho R, Storr M. Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 25: 377-83. PMID 21876860 DOI: 10.1155/2011/953975 |
0.331 |
|
| 2011 |
Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, McCafferty DM, Sharkey KA, Storr M. The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflammatory Bowel Diseases. 17: 1651-64. PMID 21744421 DOI: 10.1002/Ibd.21538 |
0.529 |
|
| 2011 |
Lin XH, Yuece B, Li YY, Feng YJ, Feng JY, Yu LY, Li K, Li YN, Storr M. A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 23: 862-e342. PMID 21726355 DOI: 10.1111/J.1365-2982.2011.01742.X |
0.368 |
|
| 2010 |
Schicho R, Storr M. Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies. Expert Review of Clinical Pharmacology. 3: 193-207. PMID 22111567 DOI: 10.1586/Ecp.09.62 |
0.327 |
|
| 2010 |
Gach K, do-Rego JC, Fichna J, Storr M, Delbro D, Toth G, Janecka A. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs. Peptides. 31: 1617-24. PMID 20434497 DOI: 10.1016/J.Peptides.2010.04.018 |
0.318 |
|
| 2010 |
Storr MA, Bashashati M, Hirota C, Vemuri VK, Keenan CM, Duncan M, Lutz B, Mackie K, Makriyannis A, Macnaughton WK, Sharkey KA. Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 22: 787-96, e223. PMID 20180825 DOI: 10.1111/J.1365-2982.2010.01478.X |
0.498 |
|
| 2010 |
Yüce B, Kemmer M, Qian G, Müller M, Sibaev A, Li Y, Kreis ME, Storr M. Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 22: 672-e205. PMID 20158615 DOI: 10.1111/J.1365-2982.2010.01473.X |
0.308 |
|
| 2010 |
Li YY, Li YN, Ni JB, Chen CJ, Lv S, Chai SY, Wu RH, Yüce B, Storr M. Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 22: 350-e88. PMID 19840270 DOI: 10.1111/J.1365-2982.2009.01419.X |
0.345 |
|
| 2009 |
Fichna J, Schicho R, Janecka A, Zjawiony JK, Storr M. Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction. Drug News & Perspectives. 22: 383-92. PMID 19890495 DOI: 10.1358/Dnp.2009.22.7.1400219 |
0.32 |
|
| 2009 |
Fichna J, Schicho R, Andrews CN, Bashashati M, Klompus M, McKay DM, Sharkey KA, Zjawiony JK, Janecka A, Storr MA. Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 21: 1326-e128. PMID 19650775 DOI: 10.1111/J.1365-2982.2009.01369.X |
0.484 |
|
| 2009 |
Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflammatory Bowel Diseases. 15: 1678-85. PMID 19408320 DOI: 10.1002/Ibd.20960 |
0.499 |
|
| 2009 |
Sibaev A, Yüce B, Kemmer M, Van Nassauw L, Broedl U, Allescher HD, Göke B, Timmermans JP, Storr M. Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon. American Journal of Physiology. Gastrointestinal and Liver Physiology. 296: G119-28. PMID 19033531 DOI: 10.1152/Ajpgi.90274.2008 |
0.321 |
|
| 2009 |
Storr M, Bashashati M, Vemuri K, Alapafuja S, Ho W, Keenan CM, Kunos G, Makriyannis A, Davison JS, Sharkey KA. W1697 Regional Specificity of Fatty Acid Amide Hydrolase (FAAH) Inhibition On Contractility in the Mouse Intestine: Endotoxin Upregulation of Faah Sensitivity in the Ileum Gastroenterology. 136: A-719. DOI: 10.1016/S0016-5085(09)63320-5 |
0.474 |
|
| 2008 |
Storr MA, Yüce B, Andrews CN, Sharkey KA. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 20: 857-68. PMID 18710476 DOI: 10.1111/J.1365-2982.2008.01175.X |
0.492 |
|
| 2008 |
Storr MA, Keenan CM, Emmerdinger D, Zhang H, Yüce B, Sibaev A, Massa F, Buckley NE, Lutz B, Göke B, Brand S, Patel KD, Sharkey KA. Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. Journal of Molecular Medicine (Berlin, Germany). 86: 925-36. PMID 18493729 DOI: 10.1007/S00109-008-0359-6 |
0.479 |
|
| 2008 |
Hons IM, Keenan CM, Storr M, Lutz B, Sharkey KA. M1239 Alterations in Synaptic Transmission in the Enteric Nervous System and Correlation to Motility Defects in CB1 Receptor-Deficient Mice Gastroenterology. 134: A-368. DOI: 10.1016/S0016-5085(08)61715-1 |
0.492 |
|
| 2008 |
Storr M, Keenan CM, Zhang H, Patel KD, Sharkey KA. S1737 Drugs Inhibiting Endocannabinoid Degradation Protect Against Experimental Colitis in Mice Gastroenterology. 134: A-260. DOI: 10.1016/S0016-5085(08)61208-1 |
0.467 |
|
| 2007 |
Storr MA, Sharkey KA. The endocannabinoid system and gut-brain signalling. Current Opinion in Pharmacology. 7: 575-82. PMID 17904903 DOI: 10.1016/j.coph.2007.08.008 |
0.473 |
|
| 2007 |
Yuece B, Sibaev A, Broedl UC, Marsicano G, Göke B, Lutz B, Allescher HD, Storr M. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 19: 744-53. PMID 17727394 DOI: 10.1111/J.1365-2982.2007.00975.X |
0.373 |
|
| 2007 |
Yüce B, Sibaev A, Haaken A, Saur D, Allescher HD, Göke B, Timmermans JP, Storr M. ORL-1 receptor mediates the action of nociceptin on ascending myenteric reflex pathways in rats. Gastroenterology. 133: 574-86. PMID 17681177 DOI: 10.1053/J.Gastro.2007.05.016 |
0.348 |
|
| 2007 |
Storr M. TRPV1 in colitis: is it a good or a bad receptor?--a viewpoint. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 19: 625-9. PMID 17539893 DOI: 10.1111/J.1365-2982.2007.00946.X |
0.344 |
|
| 2006 |
Sibaev A, Massa F, Yüce B, Marsicano G, Lehr HA, Lutz B, Göke B, Allescher HD, Storr M. CB1 and TRPV1 receptors mediate protective effects on colonic electrophysiological properties in mice. Journal of Molecular Medicine (Berlin, Germany). 84: 513-20. PMID 16501934 DOI: 10.1007/S00109-006-0040-X |
0.328 |
|
| 2006 |
Storr M, Yüce B, Göke B. [Perspectives of cannabinoids in gastroenterology]. Zeitschrift Fã¼R Gastroenterologie. 44: 185-91. PMID 16456761 DOI: 10.1055/S-2005-858931 |
0.303 |
|
| 2006 |
Massa F, Sibaev A, Marsicano G, Blaudzun H, Storr M, Lutz B. Vanilloid receptor (TRPV1)-deficient mice show increased susceptibility to dinitrobenzene sulfonic acid induced colitis. Journal of Molecular Medicine (Berlin, Germany). 84: 142-6. PMID 16389550 DOI: 10.1007/S00109-005-0016-2 |
0.381 |
|
| 2005 |
Massa F, Storr M, Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. Journal of Molecular Medicine (Berlin, Germany). 83: 944-54. PMID 16133420 DOI: 10.1007/S00109-005-0698-5 |
0.385 |
|
| 2005 |
Sibaev A, Massa F, Yüce B, Marsicano G, Lehr H, Lutz B, Göke B, Allescher H, Storr M. CB1 and TRPV1 receptors mediate protective effects on electrophysiological properties during colonic inflammation Zeitschrift FüR Gastroenterologie. 43. DOI: 10.1055/S-2005-919919 |
0.35 |
|
| 2004 |
Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M, Lutz B. The endogenous cannabinoid system protects against colonic inflammation. The Journal of Clinical Investigation. 113: 1202-9. PMID 15085199 DOI: 10.1172/Jci19465 |
0.385 |
|
| 2004 |
Storr M, Sibaev A, Marsicano G, Lutz B, Schusdziarra V, Timmermans JP, Allescher HD. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. American Journal of Physiology. Gastrointestinal and Liver Physiology. 286: G110-7. PMID 12893627 DOI: 10.1152/Ajpgi.00148.2003 |
0.334 |
|
| 2003 |
Storr M, Sibaev A, Marsicano G, Lutz B, Allescher H. Excitatory cholinergic and inhibitory non-adrenergic, non-cholinergic neurotransmission in murine colon is modulated by the CB1 cannabinoid receptor. Intracellular recording in wild-type and CB1-deficient mice Gastroenterology. 124: A116-A117. DOI: 10.1016/S0016-5085(03)80573-5 |
0.319 |
|
| 2002 |
Storr M, Thammer J, Dunkel R, Schusdziarra V, Allescher HD. Modulatory effect of adenosine receptors on the ascending and descending neural reflex responses of rat ileum. Bmc Neuroscience. 3: 21. PMID 12495441 DOI: 10.1186/1471-2202-3-21 |
0.338 |
|
| 2002 |
Storr M, Koppitz P, Sibaev A, Saur D, Kurjak M, Franck H, Schusdziarra V, Allescher HD. Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. Journal of Pineal Research. 33: 101-8. PMID 12153444 DOI: 10.1034/J.1600-079X.2002.02909.X |
0.318 |
|
| 2002 |
Storr M, Gaffal E, Schusdziarra V, Allescher HD. Endomorphins 1 and 2 reduce relaxant non-adrenergic, non-cholinergic neurotransmission in rat gastric fundus. Life Sciences. 71: 383-9. PMID 12044838 DOI: 10.1016/S0024-3205(02)01681-8 |
0.331 |
|
| 2002 |
Storr M, Hahn A, Gaffal E, Saur D, Allescher HD. Effects of endomorphin-1 and -2 on mu-opioid receptors in myenteric neurons and in the peristaltic reflex in rat small intestine. Clinical and Experimental Pharmacology & Physiology. 29: 428-34. PMID 12010188 DOI: 10.1046/J.1440-1681.2002.03681.X |
0.311 |
|
| 2002 |
Storr M, Gaffal E, Saur D, Schusdziarra V, Allescher HD. Effect of cannabinoids on neural transmission in rat gastric fundus. Canadian Journal of Physiology and Pharmacology. 80: 67-76. PMID 11911227 DOI: 10.1139/Y02-005 |
0.321 |
|
| 2000 |
Storr M, Meining A, Allescher HD. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease. Digestive Diseases (Basel, Switzerland). 18: 93-102. PMID 11060472 DOI: 10.1159/000016970 |
0.31 |
|
| 2000 |
Allescher HD, Storr M, Brechmann C, Hahn A, Schusdziarra V. Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum. Neuropeptides. 34: 62-8. PMID 10688971 DOI: 10.1054/Npep.1999.0789 |
0.301 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2005 |
Yuece B, Sibaev A, Marsicano G, Lutz B, Allescher H, Goeke B, Storr M. Pharmacological blockade and genetical ablation of the Cannabinoid-1 (CB-1) receptor stimulates peristaltic reflex and gastrointestinal transit Zeitschrift FüR Gastroenterologie. 43. DOI: 10.1055/S-2005-921814 |
0.298 |
|
| 2010 |
Alfadda AA, Urbanski SJ, Shaffer EA, Storr M. W1914 Clinical Features of Eosinophilic Colitis – A Report of 7 Consecutive Cases Gastroenterology. 138: S-765. DOI: 10.1016/S0016-5085(10)63527-5 |
0.297 |
|
| 2013 |
Gyulai Z, Udvardy A, Cs Bényei A, Fichna J, Gach K, Storr M, Tóth G, Antus S, Berényi S, Janecka A, Sipos A. Synthesis and opioid activity of novel 6-ketolevorphanol derivatives. Medicinal Chemistry (ShäRiqah (United Arab Emirates)). 9: 1-10. PMID 22741803 DOI: 10.2174/157340613804488323 |
0.297 |
|
| 2012 |
Sibaev A, Yuoce B, Kelber O, Weiser D, Abdel-Aziz H, Göke B, Storr M. Tu1989 Real Time In Vitro Monitoring of Inflammation Induced Motility Changes and Protective Effects of STW 5 in a Newly Designed Model Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)63476-3 |
0.293 |
|
| 2013 |
Li K, Feng JY, Li YY, Yuece B, Lin XH, Yu LY, Li YN, Feng YJ, Storr M. Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice. Pancreas. 42: 123-9. PMID 22850623 DOI: 10.1097/Mpa.0B013E318259F6F0 |
0.293 |
|
| 2014 |
Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease. Inflammatory Bowel Diseases. 20: 472-80. PMID 24407485 DOI: 10.1097/01.Mib.0000440982.79036.D6 |
0.292 |
|
| 2010 |
Sibaev A, Yuece B, Kelber O, Okpanyi S, Storr M. Iberis amara L. constituents reduce excitatory cholinergic and inhibitory purinergic neurotransmission Planta Medica. 76. DOI: 10.1055/S-0030-1264916 |
0.291 |
|
| 2013 |
Storr M, Vogel HJ, Schicho R. Metabolomics: is it useful for inflammatory bowel diseases? Current Opinion in Gastroenterology. 29: 378-83. PMID 23624676 DOI: 10.1097/Mog.0B013E328361F488 |
0.289 |
|
| 2017 |
Madisch A, Vinson BR, Abdel-Aziz H, Kelber O, Nieber K, Kraft K, Storr M. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders. Wiener Medizinische Wochenschrift (1946). PMID 28424994 DOI: 10.1007/S10354-017-0557-3 |
0.289 |
|
| 2013 |
Füllhase C, Campeau L, Sibaev A, Storr M, Gratzke C, Stief C, Hedlund P, Andersson K. 121 NEURONAL CONTROL OF MICTURITION VIA CANNABINOID (CB) TYPE 1 RECEPTORS - EVALUATION OF A CB1 KNOCKOUT MOUSE Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1500 |
0.289 |
|
| 2001 |
Storr M, Meining A, Allescher HD. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease. Expert Opinion On Pharmacotherapy. 2: 1099-108. PMID 11583061 DOI: 10.1517/14656566.2.7.1099 |
0.289 |
|
| 2008 |
Schäfer C, Michler T, Kramer J, Malo A, Göke B, Storr M. THE ROLE OF CB2-RECEPTORS IN ACUTE PANCREATITIS Pancreas. 37: 493-494. DOI: 10.1097/01.Mpa.0000335379.02327.90 |
0.289 |
|
| 2007 |
Li YY, Sibaev A, Zhou MZ, Zhu GY, Yüce B, Storr M. The Chinese herbal preparation Qing Yi Tang (QYT) improves intestinal myoelectrical activity and increases intestinal transit during acute pancreatitis in rodents. Phytotherapy Research : Ptr. 21: 324-31. PMID 17199239 DOI: 10.1002/Ptr.2071 |
0.288 |
|
| 2005 |
Sibaev A, Yuece B, Goeke B, Allescher H, Storr M. Evidence of changes in functional spreading of neural information within the myenteric reflex by Cannabinoid-1 receptor activation Zeitschrift FüR Gastroenterologie. 43. DOI: 10.1055/S-2005-921813 |
0.285 |
|
| 2005 |
Storr M, Linke R, Nicolaus M, Göke B, Schirra J. [Injection of botulinum toxin for diffuse esophageal spasm]. Deutsche Medizinische Wochenschrift (1946). 130: 266-9. PMID 15692899 DOI: 10.1055/S-2005-837411 |
0.284 |
|
| 2008 |
Storr M, Andrews CN. Medical management of irritable bowel syndrome in 2008: current and future directions. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 22: 673-5. PMID 18701942 DOI: 10.1155/2008/145216 |
0.283 |
|
| 2008 |
Andrews CN, Storr M. Evaluation of lower functional gut disorders. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 22: 614-6. PMID 18629389 DOI: 10.1155/2008/627197 |
0.282 |
|
| 2009 |
Mueller MH, Gong Q, Kelber O, Kasparek MS, Sibaev A, Mansmann U, Yuce B, Li YY, Storr M, Kreis ME. A novel herbal preparation desensitizes mesenteric afferents to bradykinin in the rat small intestine. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 21: 467-76. PMID 19140959 DOI: 10.1111/J.1365-2982.2008.01232.X |
0.282 |
|
| 2017 |
Mosińska P, Jacenik D, Sałaga M, Wasilewski A, Cygankiewicz A, Sibaev A, Mokrowiecka A, Małecka-Panas E, Pintelon I, Storr M, Timmermans JP, Krajewska WM, Fichna J. FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 30: e13272. PMID 29266569 DOI: 10.1111/Nmo.13272 |
0.281 |
|
| 2010 |
Czakó B, Marton J, Berényi S, Gach K, Fichna J, Storr M, Tóth G, Sipos A, Janecka A. Synthesis and opioid activity of novel 6-substituted-6-demethoxy-ethenomorphinans. Bioorganic & Medicinal Chemistry. 18: 3535-42. PMID 20413312 DOI: 10.1016/J.Bmc.2010.03.068 |
0.281 |
|
| 2001 |
Storr M, Allescher HD, Classen M. Current concepts on pathophysiology, diagnosis and treatment of diffuse oesophageal spasm. Drugs. 61: 579-91. PMID 11368284 DOI: 10.2165/00003495-200161050-00004 |
0.279 |
|
| 2014 |
Schicho R, Storr M. IBD: Patients with IBD find symptom relief in the Cannabis field. Nature Reviews. Gastroenterology & Hepatology. 11: 142-3. PMID 24366227 DOI: 10.1038/Nrgastro.2013.245 |
0.279 |
|
| 2008 |
Storr M, Kramer J, Michler T, Malo A, Göke B, Schaefer C. M1836 Acute Experimental Pancreatitis Is Ameliorated By Activation of Cannabinoid-1 (CB1) Receptors Gastroenterology. 134: A-430. DOI: 10.1016/S0016-5085(08)62008-9 |
0.279 |
|
| 2006 |
Sibaev A, Yuece B, Kelber O, Weiser D, Schirra J, Göke B, Allescher HD, Storr M. STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 13: 80-9. PMID 16713219 DOI: 10.1016/J.Phymed.2006.03.015 |
0.279 |
|
| 2010 |
Schicho R, Nazyrova A, Shaykhutdinov R, Duggan G, Vogel HJ, Storr M. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. Journal of Proteome Research. 9: 6265-73. PMID 20886908 DOI: 10.1021/Pr100547Y |
0.279 |
|
| 2011 |
Kurjak M, Fichna J, Harbarth J, Sennefelder A, Allescher HD, Schusdziarra V, Storr M, Otto B. Effect of GABA-ergic mechanisms on synaptosomal NO synthesis and the nitrergic component of NANC relaxation in rat ileum. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 23: e181-90. PMID 21414101 DOI: 10.1111/J.1365-2982.2011.01688.X |
0.278 |
|
| 2000 |
Allescher HD, Storr M, Piller C, Brantl V, Schusdziarra V. Effect of opioid active therapeutics on the ascending reflex pathway in the rat ileum. Neuropeptides. 34: 181-6. PMID 11021978 DOI: 10.1054/Npep.2000.0811 |
0.277 |
|
| 2010 |
Storr M, Emmerdinger D, Diegelmann J, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Brand S. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. Plos One. 5: e9453. PMID 20195480 DOI: 10.1371/Journal.Pone.0009453 |
0.277 |
|
| 2004 |
Storr M, Sibaev A, Weiser D, Kelber O, Schirra J, Goke B, Allescher HD. Herbal extracts modulate the amplitude and frequency of slow waves in circular smooth muscle of mouse small intestine. Digestion. 70: 257-64. PMID 15687728 DOI: 10.1159/000083718 |
0.276 |
|
| 2011 |
Andrews CN, Storr M. The pathophysiology of chronic constipation. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 25: 16B-21B. PMID 22114753 DOI: 10.1155/2011/169319 |
0.276 |
|
| 2016 |
Mosińska P, Socała K, Nieoczym D, Laudon M, Storr M, Fichna J, Wlaź P. Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice. Behavioural Brain Research. PMID 27016427 DOI: 10.1016/J.Bbr.2016.03.036 |
0.276 |
|
| 2015 |
Bokic T, Storr M, Schicho R. Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview. Pharmacology. 96: 76-85. PMID 26139425 DOI: 10.1159/000435816 |
0.275 |
|
| 2001 |
Storr M, Allescher HD, Rösch T, Born P, Weigert N, Classen M. Treatment of symptomatic diffuse esophageal spasm by endoscopic injection of botulinum toxin: a prospective study with long term follow-up. Gastrointestinal Endoscopy. 54: 18A. PMID 11762324 DOI: 10.1067/Mge.2001.119256 |
0.274 |
|
| 2010 |
Andrews CN, Syed A, Urbanski SJ, Beck PL, Storr M. S1086 The Rising Incidence of Eosinophilic Esophagitis Correlates With Increased Awareness of the Disease Gastroenterology. 138: S-176. DOI: 10.1016/S0016-5085(10)60802-5 |
0.273 |
|
| 2011 |
Andrews CN, Mintchev P, Neshev E, Fraser HF, Storr M, Bathe OF, Urbanski SJ. Percutaneous endoscopically assisted transenteric full-thickness gastric biopsy: initial experience in humans. Gastrointestinal Endoscopy. 73: 949-54. PMID 21392758 DOI: 10.1016/J.Gie.2010.12.037 |
0.273 |
|
| 2009 |
Storr M, Emmerdinger D, Diegelmann J, Yüce B, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Brand S. The role of fatty acid hydrolase gene variants in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 29: 542-51. PMID 19053981 DOI: 10.1111/J.1365-2036.2008.03910.X |
0.272 |
|
| 2004 |
Storr M, Meining A. Pharmacologic management and treatment of gastroesophageal reflux disease. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 17: 197-204. PMID 15361091 DOI: 10.1111/J.1442-2050.2004.00408.X |
0.272 |
|
| 2006 |
Sibaev A, Yüce B, Schirra J, Göke B, Allescher HD, Storr M. Are gap junctions truly involved in inhibitory neuromuscular interaction in mouse proximal colon? Clinical and Experimental Pharmacology & Physiology. 33: 740-5. PMID 16895549 DOI: 10.1111/J.1440-1681.2006.04433.X |
0.271 |
|
| 2019 |
Roggenbrod S, Schuler C, Haller B, Sohn M, Storr M, Schepp W, Gundling F. [Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis]. Zeitschrift Fur Gastroenterologie. 57: 296-303. PMID 30861553 DOI: 10.1055/A-0821-7166 |
0.27 |
|
| 2000 |
Storr M, Schusdziarra V, Allescher HD. Inhibition of small conductance K+ -channels attenuated melatonin-induced relaxation of serotonin-contracted rat gastric fundus. Canadian Journal of Physiology and Pharmacology. 78: 799-806. PMID 11077980 DOI: 10.1139/Cjpp-78-10-799 |
0.269 |
|
| 2008 |
Sibaev A, Yüce B, Allescher HD, Göke B, Storr M. A new electrophysiological tool to investigate the spatial neuronal projections within the myenteric ascending reflex of the mouse colon. Clinical and Experimental Pharmacology & Physiology. 35: 744-50. PMID 18346174 DOI: 10.1111/J.1440-1681.2008.04919.X |
0.266 |
|
| 2008 |
Kurjak M, Hamel AM, Allescher HD, Schusdziarra V, Storr M. Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum. Neuropeptides. 42: 623-32. PMID 18829105 DOI: 10.1016/J.Npep.2008.08.003 |
0.266 |
|
| 2012 |
Fichna J, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Janecka A, Krajewska WM, Storr MA. Transient receptor potential vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment? Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 24: e557-60. PMID 22882778 DOI: 10.1111/j.1365-2982.2012.01999.x |
0.265 |
|
| 2010 |
Bashashati M, Andrews C, Ghosh S, Storr M. Botulinum toxin in the treatment of diffuse esophageal spasm. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 23: 554-60. PMID 20459446 DOI: 10.1111/J.1442-2050.2010.01065.X |
0.265 |
|
| 2017 |
Abdel-Aziz H, Kelber O, Lorkowski G, Storr M. Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast. Planta Medica. PMID 28859216 DOI: 10.1055/S-0043-116852 |
0.265 |
|
| 2010 |
Sibaev A, Yüce B, Kelber O, Storr M. Die exzitatorische, cholinerge und inhibitorische, purinerge Neurotransmission wird durch Kaempferol einem Flavonoid der Iberis amara im Colon von Nagern gehemmt Zeitschrift FüR Gastroenterologie. 48. DOI: 10.1055/S-0030-1263701 |
0.265 |
|
| 2008 |
Yüce B, Emmerdinger D, Diegelmann J, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Storr M, Brand S. The influence of FAAH (Fatty Acid Hydrolase) expression and FAAH C/A (p.Pro129Thr; rs324420) single nucleotide polymorphism in patients with inflammatory bowel disease Zeitschrift FüR Gastroenterologie. 46. DOI: 10.1055/S-0028-1089585 |
0.262 |
|
| 2011 |
Kish L, Hotte N, Cheng E, Rioux KP, Kaplan GG, Vincent R, Storr M, Madsen K. Orally Ingested Urban Particulate Matter Induces a PRO-Inflammatory Response and Decreases Microflora Diversity Gastroenterology. 140: S-46-S-47. DOI: 10.1016/S0016-5085(11)60186-8 |
0.262 |
|
| 2004 |
Meining A, Fackler A, Tzavella K, Storr M, Allescher HD, Klauser A, Heldwein W. Lower esophageal sphincter pressure in patients with gastroesophageal reflux diseases and posture and time patterns. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 17: 155-8. PMID 15230730 DOI: 10.1111/J.1442-2050.2004.00394.X |
0.261 |
|
| 2010 |
Lee R, Storr M, Hershfield NB. A case of Conn's syndrome revealed after oral sodium phosphate (Fleet) preparation for colonoscopy. Journal of Digestive Diseases. 11: 111-4. PMID 20402838 DOI: 10.1111/J.1751-2980.2010.00425.X |
0.26 |
|
| 2010 |
Storr M, Allescher HD. Reflux disease as a motility disorder: treatment alternatives to acid suppression. Gastroenterology. 139: 2207-9. PMID 20970447 DOI: 10.1053/J.Gastro.2010.10.019 |
0.26 |
|
| 2010 |
Perlikowska R, Fichna J, Wyrebska A, Poels J, Vanden Broeck J, Toth G, Storr M, do Rego JC, Janecka A. Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2. Basic & Clinical Pharmacology & Toxicology. 106: 106-13. PMID 19874287 DOI: 10.1111/J.1742-7843.2009.00476.X |
0.259 |
|
| 2018 |
Keller J, Fox MR, Allescher HD, Frieling T, Fuchs KH, Goebel-Stengel M, Pehl C, Schirra J, van der Voort I, Storr M. [Interpretation und performance of high-resolution esophageal manometry: Recommendations of the German Association of Neurogastroenterology and Motility (DGNM) and the German Association of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]. Zeitschrift Fur Gastroenterologie. 56: 1378-1408. PMID 30419581 DOI: 10.1055/A-0713-0944 |
0.259 |
|
| 2013 |
Yan LM, Velkova A, Tatarek-Nossol M, Rammes G, Sibaev A, Andreetto E, Kracklauer M, Bakou M, Malideli E, Göke B, Schirra J, Storr M, Kapurniotu A. Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40. Angewandte Chemie (International Ed. in English). 52: 10378-83. PMID 23956012 DOI: 10.1002/Anie.201302840 |
0.258 |
|
| 2011 |
Allescher HD, Storr M. Is irritable bowel syndrome a rhinitis of the gut? Gastroenterology. 140: 2132-6; discussion 2. PMID 21515275 DOI: 10.1053/J.Gastro.2011.04.019 |
0.258 |
|
| 2002 |
Storr M, Born P, Frimberger E, Weigert N, Rösch T, Meining A, Classen M, Allescher HD. Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment. Bmc Gastroenterology. 2: 19. PMID 12175425 DOI: 10.1186/1471-230X-2-19 |
0.258 |
|
| 2009 |
Storr M, Andrews CN, Urbanski SJ, Dupre MP, Beck PL. S1037 Detection Bias Influences Increasing Rates of Microscopic Colitis: A Population Based Study Gastroenterology. 136: A-175. DOI: 10.1016/S0016-5085(09)60788-5 |
0.256 |
|
| 2002 |
Storr M, Folmer R, Kurjak M, Schusdziarra V, Allescher HD. Okadaic acid inhibits relaxant neural transmission in rat gastric fundus in vitro. Acta Physiologica Scandinavica. 175: 29-36. PMID 11982502 DOI: 10.1046/J.1365-201X.2002.00959.X |
0.256 |
|
| 2001 |
Allescher HD, Storr M, Seige M, Gonzales-Donoso R, Ott R, Born P, Frimberger E, Weigert N, Stier A, Kurjak M, Rösch T, Classen M. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up. Endoscopy. 33: 1007-17. PMID 11740642 DOI: 10.1055/S-2001-18935 |
0.256 |
|
| 2003 |
Storr M, Sattler D, Hahn A, Schusdziarra V, Allescher HD. Endogenous CCK depresses contractile activity within the ascending myenteric reflex pathway of rat ileum. Neuropharmacology. 44: 524-32. PMID 12646289 DOI: 10.1016/S0028-3908(03)00028-5 |
0.253 |
|
| 2018 |
Ricciuto A, Al-Darmaki A, Stewart MJ, Ding NS, Shim HH, Storr M, Panaccione R, Seow C. P457 Biological interventions for induction and maintenance of mucosal healing in ulcerative colitis: A Cochrane systematic review Journal of Crohn's and Colitis. 12: S335-S336. DOI: 10.1093/Ecco-Jcc/Jjx180.584 |
0.253 |
|
| 2019 |
Miehlke S, Schlag C, Storr M, von Arnim U. [Eosinophilic Esophagitis Update: New Guidelines of the European Study Group EUREOS]. Laryngo- Rhino- Otologie. 98: 764-775. PMID 31739353 DOI: 10.1055/A-0960-6553 |
0.253 |
|
| 2017 |
Miehlke S, Schlag C, Storr M, Arnim UV. [Eosinophilic Esophagitis Update: New Guidelines of the European Study Group EUREOS]. Zeitschrift Fur Gastroenterologie. PMID 29121691 DOI: 10.1055/S-0043-121349 |
0.253 |
|
| 2018 |
Ricciuto A, Church P, Stewart MJ, Shim HH, Storr M, Panaccione R, Griffiths AM, Seow CH. Sa1745 - Biological Interventions for Induction and Maintenance of Mucosal Healing in Crohn's Disease: A Cochrane Systematic Review Gastroenterology. 154: S-378. DOI: 10.1016/S0016-5085(18)31569-5 |
0.252 |
|
| 2018 |
Ricciuto A, Al-Darmaki A, Stewart MJ, Ding NS, Shim HH, Storr M, Panaccione R, Seow CH. Sa1754 - Biological Interventions for Induction and Maintenance of Mucosal Healing in Ulcerative Colitis: A Cochrane Systematic Review Gastroenterology. 154: S-382. DOI: 10.1016/S0016-5085(18)31578-6 |
0.252 |
|
| 2011 |
Storr M, Storr M. Chronic constipation: current management and challenges. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 25: 5B-6B. PMID 22114750 DOI: 10.1155/2011/527151 |
0.251 |
|
| 2015 |
Kraft K, Kelber O, Vinson B, Nieber K, Storr M, Madisch A. Herbal medicine for replacing prokinetics in functional GI diseases European Journal of Integrative Medicine. 7: 44. DOI: 10.1016/J.Eujim.2015.09.109 |
0.251 |
|
| 2018 |
Ricciuto A, Church P, Stewart MJ, Shim HH, Storr M, Panaccione R, Griffiths A, Seow C. P365 Biological interventions for induction and maintenance of mucosal healing in Crohn’s disease: A Cochrane systematic review Journal of Crohn's and Colitis. 12: S289-S289. DOI: 10.1093/Ecco-Jcc/Jjx180.492 |
0.251 |
|
| 2015 |
Mazurak N, Broelz E, Storr M, Enck P. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? Journal of Neurogastroenterology and Motility. 21: 471-85. PMID 26351253 DOI: 10.5056/Jnm15071 |
0.249 |
|
| 2011 |
Stewart MJ, Seow CH, Storr MA. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 9: 881-90. PMID 21699817 DOI: 10.1016/S0016-5085(11)60119-4 |
0.249 |
|
| 1998 |
Huber A, Trudrung P, Storr M, Franck H, Schusdziarra V, Ruth P, Allescher HD. Protein kinase G expression in the small intestine and functional importance for smooth muscle relaxation. The American Journal of Physiology. 275: G629-37. PMID 9756490 DOI: 10.1152/Ajpgi.1998.275.4.G629 |
0.249 |
|
| 2012 |
Stewart MJ, Garg SK, Seow CH, Storr M. Interventions for induction and maintenance of mucosal healing in Crohn's disease Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd010141 |
0.248 |
|
| 2012 |
Storr M, Allescher HD. Irritable bowel syndrome: a dysfunction of the endocannabinoid system? Gastroenterology. 142: 406-8. PMID 22192431 DOI: 10.1053/J.Gastro.2011.12.028 |
0.248 |
|
| 2014 |
Stewart MJ, Kutcher M, Storr M, Seow CH. Interventions for maintenance of mucosal healing in ulcerative colitis Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd010998 |
0.248 |
|
| 2019 |
Peri R, Aguilar RC, Tüffers K, Erhardt A, Link A, Ehlermann P, Angeli W, Frank T, Storr M, Glück T, Sturm A, Rosien U, Tacke F, Bachmann O, Solbach P, et al. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent infections in Germany. United European Gastroenterology Journal. 7: 716-722. PMID 31210950 DOI: 10.1177/2050640619839918 |
0.247 |
|
| 2000 |
Storr M, Franck H, Saur D, Schusdziarra V, Allescher HD. Mechanisms of alpha,beta-methylene atp-induced inhibition in rat ileal smooth muscle: involvement of intracellular Ca2+ stores in purinergic inhibition. Clinical and Experimental Pharmacology & Physiology. 27: 771-9. PMID 11022968 DOI: 10.1046/J.1440-1681.2000.03334.X |
0.247 |
|
| 2017 |
Ricciuto A, Church PC, Stewart MJ, Shim HH, Storr M, Griffiths AM, Seow CH. Biological interventions for maintenance of mucosal healing in Crohn’s disease Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd012677 |
0.247 |
|
| 2014 |
Stewart MJ, Kutcher M, Storr M, Seow CH. Interventions for induction of mucosal healing in ulcerative colitis Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd010997 |
0.246 |
|
| 2016 |
Bashashati M, Fichna J, Piscitelli F, Capasso R, Izzo A, Sibaev A, Timmermans J, Cenac N, Vergnolle N, Marzo VD, Storr M. 184 Regulation of the Enteric Neuromotor and Sensory Functions in the Mouse With N-Arachidonoyl-Serotonin (AA-5-HT), a Dual Fatty Acid Amide Hydrolase (FAAH) Inhibitor and TRPV1 Antagonist Gastroenterology. 150: S48. DOI: 10.1016/S0016-5085(16)30285-2 |
0.246 |
|
| 2013 |
Linton MS, Zhao L, Gui X, Storr M, Andrews CN. Lichen planus is an uncommon cause of nonspecific proximal esophageal inflammation. Gut and Liver. 7: 401-5. PMID 23898378 DOI: 10.5009/Gnl.2013.7.4.401 |
0.246 |
|
| 2017 |
Ricciuto A, Church PC, Stewart MJ, Shim HH, Storr M, Griffiths AM, Seow CH. Biological interventions for induction of mucosal healing in Crohn’s disease Cochrane Database of Systematic Reviews. 2017. DOI: 10.1002/14651858.Cd012674 |
0.245 |
|
| 2006 |
Schirra J, Nicolaus M, Roggel R, Katschinski M, Storr M, Woerle HJ, Göke B. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut. 55: 243-51. PMID 15985560 DOI: 10.1136/Gut.2004.059741 |
0.245 |
|
| 2015 |
Kurjak M, Hamel A, Storr M, Saur D, Allescher H. Anandamid stimuliert die NO Synthese in enterischen Synaptosomen über einen nicht-CB1 / nicht-CB2-Rezeptor Zeitschrift FüR Gastroenterologie. 41. DOI: 10.1055/S-0035-1555501 |
0.245 |
|
| 2004 |
Sibaev A, Allescher H, Göke B, Schirra J, Storr M. Are different gap junctions involved in neuromuscular interaction in mouse proximal colon? Zeitschrift FüR Gastroenterologie. 42. DOI: 10.1055/S-2004-831498 |
0.244 |
|
| 2002 |
Geisler F, Storr M, Fritsch R, Rösch T, Classen M, Allescher HD. Endoscopic treatment of a Zenker's diverticulum using argon plasma coagulation in a patient with massive cachexia and esophageal obstruction: a case report and review of literature. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 15: 180-5. PMID 12220429 DOI: 10.1046/J.1442-2050.2002.00231.X |
0.243 |
|
| 2012 |
Kaplan GG, Szyszkowicz M, Fichna J, Rowe BH, Porada E, Vincent R, Madsen K, Ghosh S, Storr M. Non-specific abdominal pain and air pollution: a novel association. Plos One. 7: e47669. PMID 23118887 DOI: 10.1371/Journal.Pone.0047669 |
0.242 |
|
| 2001 |
Storr M, Geisler F, Neuhuber WL, Schusdziarra V, Allescher HD. Characterization of vagal input to the rat esophageal muscle. Autonomic Neuroscience : Basic & Clinical. 91: 1-9. PMID 11515794 DOI: 10.1016/S1566-0702(01)00290-9 |
0.242 |
|
| 2012 |
Andrews CN, Beck PL, Wilsack L, Urbanski SJ, Storr M. Evaluation of endoscopist and pathologist factors affecting the incidence of microscopic colitis. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 26: 515-20. PMID 22891175 DOI: 10.1155/2012/379670 |
0.241 |
|
| 2011 |
Quan S, Molodecky NA, Frolkis A, Proulx M, Lang E, Myers RP, Storr M, Kaplan GG. Hospitalizations for Upper Gastrointestinal Bleeding Secondary to Peptic Ulcer Disease: A Population-Based Validation and Epidemiological Study Gastroenterology. 140: S-730. DOI: 10.1016/S0016-5085(11)63033-3 |
0.241 |
|
| 2010 |
Fraser H, Neshev E, Storr M, Urbanski SJ, Andrews CN. A novel method of full-thickness gastric biopsy via a percutaneous, endoscopically assisted, transenteric approach. Gastrointestinal Endoscopy. 71: 831-4. PMID 20363426 DOI: 10.1016/J.Gie.2009.11.048 |
0.24 |
|
| 2002 |
Storr M, Allescher HD. [Using botulinum toxin type A in the gastrointestinal tract]. Medizinische Klinik (Munich, Germany : 1983). 97: 396-401. PMID 12168477 DOI: 10.1007/S00063-002-1172-6 |
0.24 |
|
| 2013 |
Klein S, Sibaev A, Storr M, Schmid RM, Saur D. Su2048 Interstitial Cells of Cajal Integrate Excitatory and Inhibitory Neurotransmission With Intestinal Slow Wave Activity Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)62010-7 |
0.239 |
|
| 2016 |
Hagel S, Fischer A, Ehlermann P, Frank T, Tueffers K, Sturm A, Link A, Demir M, Siebenhaar A, Storr M, Glueck T, Siegel E, Solbach P, Goeser F, Koelbel CB, et al. Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile Infection. Deutsches Arzteblatt International. 113: 583-9. PMID 27658471 DOI: 10.3238/Arztebl.2016.0583 |
0.238 |
|
| 2009 |
Keller J, van der Voort I, Pehl C, Nicolaus M, Schirra J, Fox M, Fuchs K, Storr M. [Performance and interpretation of esophageal manometry: recommendations of the German Societies for Neurogastroenterology and Motility (DGNM), for Digestive and Metabolic Diseases (DGVS) and for General and Visceral Surgery (DGAV)]. Zeitschrift Fã¼R Gastroenterologie. 47: 830-45. PMID 19750432 DOI: 10.1055/S-0028-1109502 |
0.238 |
|
| 2017 |
Sibaev A, Botteselle L, Storr M. Interaktion zwischen GPR-119 und CB1-Rezeptoren bei der Modulation der gastrointestinalen Motilität Zeitschrift FüR Gastroenterologie. 55: e1-e27. DOI: 10.1055/S-0037-1603052 |
0.238 |
|
| 1998 |
Storr M, Weigert N, Fellbaum C, Classen M. [Polyposis of the gastrointestinal tract as a manifestation of diffuse follicular lymphatic hyperplasia]. Deutsche Medizinische Wochenschrift (1946). 123: 347-52. PMID 9551038 DOI: 10.1055/S-2007-1023970 |
0.237 |
|
| 2005 |
Keller J, Franke A, Storr M, Wiedbrauck F, Schirra J. [Clinically relevant breath tests in gastroenterological diagnostics--recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases]. Zeitschrift Fã¼R Gastroenterologie. 43: 1071-90. PMID 16142616 DOI: 10.1055/S-2005-858479 |
0.237 |
|
| 2015 |
Madisch A, Vinson B, Abdel-Aziz H, Kelber O, Nieber K, Kraft K, Storr M. Regulatory restrictions in prokinetic drugs: Phytotherapy to fill the gap left by cisapride, metoclopramide and domperidone in the therapy of functional gastrointestinal diseases Planta Medica. 81. DOI: 10.1055/S-0035-1565378 |
0.236 |
|
| 2010 |
Andrews CN, Fraser HF, Neshev E, Mintchev P, Storr M, Bathe OF, Urbanski SJ. 1080j: Full-Thickness Gastric Biopsy: A Novel Percutaneous Endoscopic Transenteric (PEATE) Approach in Humans With Gastroparesis Gastrointestinal Endoscopy. 71: AB144. DOI: 10.1016/J.Gie.2010.03.149 |
0.236 |
|
| 2013 |
Sibaev A, Yan L, Andreetto E, Tatarek-Nossol M, Göke B, Schirra J, Kapurniotu A, Storr M. Charakterisierung und ex vivo physiologische Wirkung eines neu-entwickelten löslichen Amylin-Analogons Zeitschrift Fur Gastroenterologie. 51. DOI: 10.1055/S-0033-1352928 |
0.236 |
|
| 2014 |
Venkatesan T, Sengupta J, Lodhi A, Schroeder A, Adams K, Hogan WJ, Wang Y, Andrews C, Storr M. An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS). Experimental Brain Research. 232: 2563-70. PMID 24792504 DOI: 10.1007/S00221-014-3967-0 |
0.236 |
|
| 2015 |
Mosińska P, Storr M, Fichna J. The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective. Therapeutic Advances in Gastroenterology. 8: 278-84. PMID 26327918 DOI: 10.1177/1756283X15587866 |
0.235 |
|
| 2015 |
Sibaev A, Abdel-Aziz H, Kelber O, Allescher H, Storr M. STW 5 (Iberogast®) und seine einzelnen pflanzlichen Extrakte modulieren Kontraktilität und Neurotransmission im humanen Kolon in vitro Zeitschrift FüR Gastroenterologie. 53. DOI: 10.1055/S-0035-1559272 |
0.235 |
|
| 2001 |
Storr M, Gaffal E, Saur D, Schusdziarra V, Allescher HD. Involvement of cannabinoids in neural transmission in rat gastric fundus Gastroenterology. 120: A97. DOI: 10.1016/S0016-5085(08)80476-3 |
0.234 |
|
| 2004 |
Frieling T, Rühl A, Becker-Boost E, Erckenbrecht J, Hagemann D, Huettl T, Keller J, Kreis M, Kuhlbusch R, Mönnikes H, Nordmann T, Pehl C, Schirra J, Storr M, Voderholzer W, et al. Hygiene im Manometrielabor: Deutsche Multicenter-Studie Zeitschrift FüR Gastroenterologie. 42. DOI: 10.1055/S-2004-831471 |
0.233 |
|
| 2012 |
Syed AA, Andrews CN, Shaffer E, Urbanski SJ, Beck P, Storr M. The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study. Alimentary Pharmacology & Therapeutics. 36: 950-8. PMID 22994460 DOI: 10.1111/Apt.12053 |
0.23 |
|
| 2015 |
Kurjak M, Hamel A, Storr M, Saur D, Allescher H. Der CB2-Rezeptor vermittelt die Stimulation der VIP-Sekretion durch Cannabinoide an Synapsen enterischer Nerven Zeitschrift FüR Gastroenterologie. 41. DOI: 10.1055/S-0035-1555505 |
0.229 |
|
| 2012 |
Sibaev A, Yüce B, Kelber O, Weiser D, Abdel-Aziz H, Göke B, Storr M. Antiinflammatorische Wirkung von STW 5 (Iberogast®) auf die durch Entzündungsvorgänge veränderte Motilität und intestinale Neurotransmission in vitro Zeitschrift FüR Gastroenterologie. 50. DOI: 10.1055/S-0032-1324175 |
0.229 |
|
| 2018 |
Auer PG, Enck P, Häuser W, Stengel A, Storr M, Langhorst J. [Psychosomatics in gastroenterology - statement of the Work Group for Psychosomatics in Gastroenterology of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]. Zeitschrift Fur Gastroenterologie. 56: 684-689. PMID 29890563 DOI: 10.1055/A-0599-1248 |
0.228 |
|
| 1995 |
Franck H, Storr M, Puschmann A, Allescher H. Cellular mechanisms of the no-induced inhibition in rat ileum: Involvement of intracellular Ca2+ stores Gastroenterology. 108: A601. DOI: 10.1016/0016-5085(95)26717-4 |
0.227 |
|
| 2011 |
Stewart M, Andrews CN, Urbanski S, Beck PL, Storr M. The association of coeliac disease and microscopic colitis: a large population-based study. Alimentary Pharmacology & Therapeutics. 33: 1340-9. PMID 21517923 DOI: 10.1111/J.1365-2036.2011.04666.X |
0.227 |
|
| 2014 |
Sałaga M, Polepally PR, Sobczak M, Grzywacz D, Kamysz W, Sibaev A, Storr M, Do Rego JC, Zjawiony JK, Fichna J. Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. The Journal of Pharmacology and Experimental Therapeutics. 350: 69-78. PMID 24891526 DOI: 10.1124/jpet.114.214239 |
0.227 |
|
| 2001 |
Gonzalez R, Storr M, Bloching H, Seige M, Ott R, Allescher HD. Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement. Journal of Clinical Gastroenterology. 32: 123-7. PMID 11205646 DOI: 10.1097/00004836-200102000-00006 |
0.226 |
|
| 2006 |
Yüce B, Haaken A, Sibaev A, Saur D, Timmermans J, Göke B, Storr M. Modulation der cholinergen Neurotransmission im Dünn- und Dickdarm der Maus und Ratte durch Agonismus am ORL1-Rezeptor Zeitschrift FüR Gastroenterologie. 44. DOI: 10.1055/S-2006-950966 |
0.225 |
|
| 2011 |
Yüce B, Merz D, Sibaev A, Göke B, Storr M. Cannabinoidrezeptor (CB1) Aktivierung reduziert direkte Kontraktionen der glatten Muskulatur des Ösophagus der Ratte Zeitschrift FüR Gastroenterologie. 49. DOI: 10.1055/S-0031-1285411 |
0.224 |
|
| 2017 |
Sibaev A, Abdel-Aziz H, Kelber O, Storr M. Die Wirkungsweise der Einzel-Extrakte von STW 5 in Kombination mit Iberis amara auf die intestinale Neurotransmission und Motilität in vitro Viszeralmedizin. 55. DOI: 10.1055/S-0037-1605149 |
0.223 |
|
| 2012 |
Rezaie A, Cheng EJ, Jijon HB, Kumar S, Storr M. Prucalopride for the treatment of chronic constipation Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd009636 |
0.222 |
|
| 2012 |
Andrews CN, Sadowski DC, Lazarescu A, Williams C, Neshev E, Storr M, Au F, Heitman SJ. Unsedated peroral wireless pH capsule placement vs. standard pH testing: a randomized study and cost analysis. Bmc Gastroenterology. 12: 58. PMID 22650250 DOI: 10.1186/1471-230X-12-58 |
0.222 |
|
| 2000 |
Storr M, Geisler F, Neuhuber W, Schusdziarra V, Allescher H. Further evidence against NO involvement in rat esophageal striated muscle innervation Gastroenterology. 118: A1199. DOI: 10.1016/S0016-5085(00)80627-7 |
0.222 |
|
| 2009 |
Sibaev A, Yüce B, Allescher H, Göke B, Storr M. Der ORL (Orphan Opioid Rezeptor 1) reguliert die Ausbreitung myenterischer Signale im Kolon der Maus Zeitschrift FüR Gastroenterologie. 47. DOI: 10.1055/S-0029-1241421 |
0.222 |
|
| 2018 |
Storr M. Reizdarmtherapie ohne Medikamente Gastro-News. 5: 23-24. DOI: 10.1007/S15006-018-1226-1 |
0.221 |
|
| 2009 |
Kaplan GG, Rowe BH, Storr M, Szyszkowicz M. 1055 Non-Specific Abdominal Pain and Air Pollution: A Novel Association Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)60728-9 |
0.221 |
|
| 2000 |
Storr M, Allescher HD, Roesch T, Born P, Weigert N, Classen M. Treatment of symptomatic diffuse esophageal spasm by injection of botulinum toxin (BTX) Gastroenterology. 118: A135. DOI: 10.1016/S0016-5085(00)82617-7 |
0.22 |
|
| 2010 |
Sibaev A, Yuece B, Kelber O, Storr M. W1945 Kaempferol and Cucurbitacin E Cardinal Constituents of Iberis Amara Reduce Excitatory Cholinergic and Inhibitory Purinergic Neurotransmission in Rodents Gastroenterology. 138: S-772. DOI: 10.1016/S0016-5085(10)63558-5 |
0.22 |
|
| 2016 |
Jarmuż A, Banaszek M, Leń K, Storr M, Zielińska M, Fichna J. The role of MOP and DOP receptors in treatment of diarrhea-predominant irritable bowel syndrome. Mini Reviews in Medicinal Chemistry. PMID 27494245 |
0.219 |
|
| 2005 |
Sibaev A, Yuece B, Kelber O, Schirra J, Göke B, Storr M. STW 5 (Iberogast®) und seine einzelnen pflanzlichen Extrakte modulieren Elektrophysiologie und Neurotransmission im Gastrointestinaltrakt der Maus Zeitschrift FüR Gastroenterologie. 43. DOI: 10.1055/S-2005-920205 |
0.219 |
|
| 2014 |
Salaga M, Storr M, Fichna J. Cross-talk between serotonin and cannabinoid signaling in the gut, new insights and future perspectives. Pain. 155: 2204-5. PMID 25109671 DOI: 10.1016/J.Pain.2014.08.002 |
0.218 |
|
| 2004 |
Schirra J, Nicolaus M, Struckmeier C, Storr M, Göke B. Endogenes GLP–1(7–36)amid (GLP–1): Regulation der Freisetzung und Wirkung auf die endokrine Pankreassekretion beim Menschen Zeitschrift FüR Gastroenterologie. 42. DOI: 10.1055/S-2004-831409 |
0.218 |
|
| 2011 |
Sibaev A, Yüce B, Kelber O, Weiser D, Goeke B, Storr M. Wirkungsweise von Iberogast® und seinen Einzelextrakten auf die durch Entzündungsvorgänge veränderte intestinale Neurotransmission Zeitschrift FüR Gastroenterologie. 49. DOI: 10.1055/S-0031-1285410 |
0.217 |
|
| 2006 |
Kelber O, Yuece B, Wallbach J, Sibaev A, Weiser D, Goeke B, Storr M. Modulation of the peristaltic reflex of rat ileum segments by STW 5 (Iberogast®) Planta Medica. 72. DOI: 10.1055/S-2006-950126 |
0.217 |
|
| 2014 |
Fichna J, Sałaga M, Stuart J, Saur D, Sobczak M, Zatorski H, Timmermans JP, Bradshaw HB, Ahn K, Storr MA. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 26: 470-81. PMID 24460851 DOI: 10.1111/nmo.12272 |
0.216 |
|
| 2003 |
Storr M, Roesch T, Born P, Prinz C, Kurjak M, Allescher H. Long-term treatment of symptomatic diffuse esophageal spasm by injection of botulinum toxin (BTX) Gastroenterology. 124: A237. DOI: 10.1016/S0016-5085(03)81190-3 |
0.215 |
|
| 2005 |
Yüce B, Sibaev A, Marsciano G, Lutz B, Schirra J, Allescher H, Göke B, Storr M. Die pharmakologische Blockade und genetische Ablation des Cannabinoid–1 (CB–1) Rezeptors stimulieren den myenterisches Reflex und den gastrointestinalen Transit Zeitschrift FüR Gastroenterologie. 43. DOI: 10.1055/S-2005-920193 |
0.215 |
|
| 2006 |
Storr M, Göke B, Wagner A. An unusual cause of azathioprine inefficacy. Endoscopy. 38: E61. PMID 17366418 DOI: 10.1055/S-2006-944706 |
0.214 |
|
| 2005 |
Storr M. Balloon dilation in patients with diffuse esophageal spasm. Gastrointestinal Endoscopy. 61: 501. PMID 15758941 DOI: 10.1016/S0016-5107(04)02792-0 |
0.212 |
|
| 1998 |
Franck H, Storr M, Puschmann A, Schusdziarra V, Allescher HD. Involvement of intracellular Ca2+ stores in inhibitory effects of NO donor SIN-1 and cGMP. The American Journal of Physiology. 275: G159-68. PMID 9655696 DOI: 10.1152/Ajpgi.1998.275.1.G159 |
0.211 |
|
| 2004 |
Storr M, Sibaev A, Schirra J, Weiser D, Kelber O, Göke B, Allescher H. Back to the roots? Phytopharmaka modulieren Amplitude und Frequenz der „slow-waves“ am Dünndarm Zeitschrift FüR Gastroenterologie. 42. DOI: 10.1055/S-2004-835789 |
0.211 |
|
| 2003 |
Sibaev A, Franck H, Vanderwinden JM, Allescher HD, Storr M. Structural differences in the enteric neural network in murine colon: impact on electrophysiology. American Journal of Physiology. Gastrointestinal and Liver Physiology. 285: G1325-34. PMID 12881230 DOI: 10.1152/Ajpgi.00506.2002 |
0.21 |
|
| 2007 |
Schäfer C, Kramer J, Malo A, Michler T, Göke B, Storr M. FLUSH OR NEW THERAPEUTIC OPTIONS Pancreas. 35: 425. DOI: 10.1097/01.Mpa.0000297778.87400.12 |
0.21 |
|
| 2017 |
Storr M, Waggershauser C. [Four reasons for the bloated abdomen of your patient]. Mmw Fortschritte Der Medizin. 159: 43-48. PMID 29159608 DOI: 10.1007/S15006-017-9601-X |
0.21 |
|
| 2007 |
Storr M, Malo A, Michler T, Göke B, Schäfer C. Rausch oder neuer Therapieansatz: Die Rolle von CB2-Rezeptoren bei der akuten Pankreatitis – Untersuchungen an einem Mausmodell Zeitschrift FüR Gastroenterologie. 45. DOI: 10.1055/S-2007-988428 |
0.209 |
|
| 2007 |
Brand S, Dambacher J, Beigel F, Zitzmann K, Heeg MH, Weiss TS, Prüfer T, Olszak T, Steib CJ, Storr M, Göke B, Diepolder H, Bilzer M, Thasler WE, Auernhammer CJ. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. American Journal of Physiology. Gastrointestinal and Liver Physiology. 292: G1019-28. PMID 17204547 DOI: 10.1152/Ajpgi.00239.2006 |
0.208 |
|
| 2012 |
Fichna J, Dicay M, Lewellyn K, Janecka A, Zjawiony JK, MacNaughton WK, Storr MA. Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors. Inflammatory Bowel Diseases. 18: 1137-45. PMID 21953882 DOI: 10.1002/ibd.21873 |
0.207 |
|
| 2009 |
Williams CI, Neshev E, Heitman SJ, Storr M, Cole M, Andrews CN. S1897 Peroral Non-Endoscopic BRAVO™ Wireless pH Capsule Insertion Versus Conventional Catheter-Based pH Monitoring: A Prospective, Randomized Trial Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)61312-3 |
0.203 |
|
| 2006 |
Yüce B, Wallbach J, Sibaev A, Schirra J, Kelber O, Göke B, Storr M. Iberogast und seine Bestandteile beeinflussen den peristaltischen Reflex am Dünndarm der Ratte Zeitschrift FüR Gastroenterologie. 44. DOI: 10.1055/S-2006-955536 |
0.202 |
|
| 2009 |
Storr M, Gao ZH, Hershfield N. Nonprogressive, long-term dysphagia in a patient with esophageal lichen planus. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 7: A24. PMID 18986843 DOI: 10.1016/J.Cgh.2008.07.028 |
0.202 |
|
| 2011 |
Fichna J, Dicay M, Hirota SA, Traboulsi D, Macdonald JA, Janecka A, Beck PL, Zjawiony JK, Macnaughton WK, Storr MA. Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 23: 583-e212. PMID 21414104 DOI: 10.1111/j.1365-2982.2011.01699.x |
0.202 |
|
| 2005 |
Wörle J, Albrecht M, Linke R, Nicolaus M, Storr M, Limmer J, Göke B, Schirra J. Gastric emptying (GE), major contributor for postprandial hyperglycemia in type 1 diabetes mellitus (T1DM) Zeitschrift FüR Gastroenterologie. 43. DOI: 10.1055/S-2005-920234 |
0.201 |
|
| 2015 |
Nieber K, Kelber O, Vinson B, Madisch A, Kraft K, Storr M. Phytopharmaka versus Prokinetika: Wirksamkeitsäquivalenz bei funktionellen Magen-Darm-Erkrankungen? Zeitschrift FüR Gastroenterologie. 53. DOI: 10.1055/S-0035-1559278 |
0.201 |
|
| 2006 |
Schirra J, Krause E, Nicolaus M, Storr M, Gürkov R, Göke B. Endoskopische Injektion von Botulinumtoxin A bei einem Patienten mit oropharyngealer Dysphagie bei cricopharyngealer Spastik Zeitschrift FüR Gastroenterologie. 44. DOI: 10.1055/S-2006-951217 |
0.201 |
|
| 2009 |
Yüce B, Sibaev A, Kelber O, Raab M, Müller M, Kreis M, Göke B, Storr M. Kämpferol – ein Flavanoid des Iberis amara Extraktes (STW 6) von Iberogast®– und der Gesamtextrakt hemmen elektrisch induzierte Kontraktionen des Ileums und modulieren elektrophysiologische Parameter im proximalen Kolon der Maus Zeitschrift FüR Gastroenterologie. 47. DOI: 10.1055/S-0029-1241431 |
0.2 |
|
| 2004 |
Lechner M, Nicolaus M, Storr M, Göke B, Schirra J. GLP–1 sensibilisiert für gastrale Dehnungsreize unabhängig von seiner Wirkung auf die gastrale Motorik Zeitschrift FüR Gastroenterologie. 42. DOI: 10.1055/S-2004-831482 |
0.2 |
|
| 2015 |
Lorkowski G, Kelber O, Abdel-Aziz H, Okpanyi S, Nieber K, Storr M. Multi-step evaluation of data on the multi-target effect of STW 5 Planta Medica. 81. DOI: 10.1055/S-0035-1565734 |
0.2 |
|
| 2011 |
Syed A, Andrews CN, Urbanski SJ, Shaffer EA, Beck PL, Storr M. Rising Esophageal Biopsy Rate is the Main Confounding Factor of Increasing Incidence of Eosinophilic Esophagitis: A Population Based Study Gastroenterology. 140: S-244. DOI: 10.1016/S0016-5085(11)60980-3 |
0.2 |
|
| 2002 |
Fritsch R, Storr M, Geisler F, Kurjak M, Berger H, Rösch T, Allescher HD, Classen M. Simultaneous perforation of three major liver blood vessels by percutaneous transhepatic biliary drainage. Endoscopy. 34: 844. PMID 12244514 DOI: 10.1055/S-2002-34253 |
0.2 |
|
| 2010 |
Fichna J, Gach K, Perlikowska R, Cravezic A, Bonnet JJ, do-Rego JC, Janecka A, Storr MA. Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract. Regulatory Peptides. 162: 109-14. PMID 20083143 DOI: 10.1016/j.regpep.2010.01.001 |
0.2 |
|
| 2012 |
Pehl C, Keller J, Allescher HD, Feussner H, Frieling T, Goebel-Stengel M, Gschossmann J, Kuhlbusch-Zicklam R, Mönnikes H, Nguyen HN, Müller M, Schirra J, Storr M, van der Voort I, Yüce B. [Diagnosis of oesophageal reflux by PH, impedance, and bilirubin measurement: recommendations of the German Society of Neurogastroenterology and of the working group for neurogastroenterology of the German Society for Digestive and Metabolic Diseases]. Zeitschrift Fã¼R Gastroenterologie. 50: 1310-32. PMID 23225560 DOI: 10.1055/S-0032-1325483 |
0.199 |
|
| 2006 |
Dambacher J, Beigel F, Zitzmann K, Olszak T, Prüfer T, Steib CJ, Storr M, Göke B, Diepolder H, Bilzer M, Auernhammer CJ, Brand S. IL-22 mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression Zeitschrift Fur Gastroenterologie. 44. DOI: 10.1055/S-2006-955513 |
0.198 |
|
| 2018 |
Grill M, Hasenoehrl C, Storr M, Schicho R. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon? Medical Cannabis and Cannabinoids. 1: 28-35. PMID 34676319 DOI: 10.1159/000489036 |
0.198 |
|
| 2011 |
Fichna J, Dicay M, Altier C, Lewellyn K, Zjawiony JK, MacNaughton WK, Janecka A, Storr MA. κ-opioid and cannabinoid-1 receptors mediate anti-inflammatory and antinociceptive effect of salvinorin a on experimental colitis in mice Pharmacological Reports. 63: 248. DOI: 10.1016/S1734-1140(11)70472-8 |
0.198 |
|
| 2013 |
Yan L, Velkova A, Tatarek-Nossol M, Rammes G, Sibaev A, Andreetto E, Kracklauer M, Bakou M, Malideli E, Göke B, Schirra J, Storr M, Kapurniotu A. Selektiv N-methylierte lösliche IAPP-Mimetika als potente IAPP-Rezeptoragonisten und nanomolare Inhibitoren der Selbstassoziation von IAPP und Aβ40 Angewandte Chemie. 125: 10569-10574. DOI: 10.1002/Ange.201302840 |
0.198 |
|
| 2011 |
Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: an update on pathophysiology and treatment. British Medical Bulletin. 100: 59-72. PMID 22012125 DOI: 10.1093/bmb/ldr045 |
0.198 |
|
| 2006 |
Storr M, Göke B, Diepolder HM. An unusual cause of intractable vomiting after cisplatin chemotherapy. Endoscopy. 38: E54. PMID 17366412 DOI: 10.1055/S-2006-944697 |
0.197 |
|
| 2017 |
Waggershauser CH, Allescher HD, Storr M. [Current treatment of dyspepsia in primary care]. Mmw Fortschritte Der Medizin. 159: 46-54. PMID 28417420 DOI: 10.1007/S15006-017-9044-4 |
0.197 |
|
| 2006 |
Wörle H, Albrecht M, Linke R, Nicolaus M, Storr M, Limmer J, Zschau S, Neumann C, Göke B, Schirra J. Mechanisms by which the amylin analog pramlintide reduces postprandial glucose (PPG) excursions in humans: Important role for splanchnic glucose sequestration Zeitschrift FüR Gastroenterologie. 44. DOI: 10.1055/S-2006-950991 |
0.196 |
|
| 2015 |
Allescher H, Reichenberger J, Egger K, Kurjak M, Rösch T, Storr M. Endoskopische Antirefluxtherapie mit der Gatekeeper-Methode: Prospektive Evaluation von Sicherheit und klinischer Effektivität Zeitschrift FüR Gastroenterologie. 41. DOI: 10.1055/S-0035-1555574 |
0.194 |
|
| 2004 |
Storr M, Sibaev A, Weiser D, Kelber O, Göke B, Schirra J, Allescher H. Das Phytotherapeutikum STW 5 (Iberogast®) und seine Einzelextrakte modulieren Amplitude und Frequenz der „slow-waves“ am Dünndarm Zeitschrift FüR Gastroenterologie. 42. DOI: 10.1055/S-2004-831484 |
0.194 |
|
| 2006 |
Woerle H, Albrecht M, Nicolaus M, Storr M, Zschau S, Neumann C, Göke B, Schirra J. Verlangsamung der Magenentleerungsgeschwindigkeit (MEG) vermindert den postprandialen Glukose (PPG)-Anstieg bei gesunden Probanden: Das Amylin Analogon Pramlintide (PRAM) reduzierte PPG-Anstiege vorwiegend durch eine vermehrte hepatische Glukosesequestrierung Diabetologie Und Stoffwechsel. 1. DOI: 10.1055/S-2006-943949 |
0.191 |
|
| 2013 |
Sibaev A, Abdel-Aziz H, Kelber O, Weiser D, Göke B, Storr M. Antiinflammatorische Wirkung von STW 5 (Iberogast®) und seinen Einzelextrakten auf die durch Entzündungsvorgänge veränderte Motilität in vitro Zeitschrift FüR Gastroenterologie. 51. DOI: 10.1055/S-0033-1352831 |
0.191 |
|
| 2006 |
Beigel F, Dambacher J, Zitzmann K, Storr M, Olszak T, Goeke B, Auernhammer C, Kaul A, Bartenschlager R, Diepolder H, Brand S. The novel Lambda-interferons IL-28A and IL-29 inhibit HCV replication in vitro and hepatic IL-28 mRNA expression is increased in HCV and CMV infection in vivo Zeitschrift FüR Gastroenterologie. 44. DOI: 10.1055/S-2006-955515 |
0.19 |
|
| 2012 |
Nasser Y, Thakrar MV, Helmersen D, Storr M, Andrews CN. Su1059 Gastroesophageal Reflux in Pre- and Post-Lung Transplantation Patient Gastroenterology. 142: S-413. DOI: 10.1016/S0016-5085(12)61559-5 |
0.19 |
|
| 2014 |
Sobczak M, Sałaga M, Storr MA, Fichna J. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. Journal of Gastroenterology. 49: 24-45. PMID 23397116 DOI: 10.1007/s00535-013-0753-x |
0.183 |
|
| 2017 |
Müller J, Vinson B, Fink C, Rabini S, Kelber O, Nieber K, Storr M, Kraft K. Das pflanzliche Arzneimittel STW 5 ist bei Patienten aller Altersgruppen wirksam – Subgruppenanalyse randomisierter kontrollierter Studien Viszeralmedizin. DOI: 10.1055/S-0037-1604835 |
0.181 |
|
| 2016 |
Storr M, Müller J, Vinson B, Rabini S, Kelber O, Kraft K. Origninaldatenbasierte Metaanalyse randomisierter placebokontrollierter Doppelblindstudien zu STW 5 Zeitschrift FüR Gastroenterologie. 54. DOI: 10.1055/S-0036-1587121 |
0.181 |
|
| 2010 |
Fichna J, Perlikowska R, Gach K, do-Rego JC, Cravezic A, Janecka A, Storr MA. The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro. Chemical Biology & Drug Design. 76: 77-81. PMID 20456368 DOI: 10.1111/j.1747-0285.2010.00977.x |
0.179 |
|
| 2015 |
Lorkowski G, Kelber O, Abdel-Aziz H, Nieber K, Storr M. Handling of complex data in gastroenterology: Multi-step clustering of preclinical data on a combination phytomedicine, STW 5 Zeitschrift FüR Gastroenterologie. 53. DOI: 10.1055/S-0035-1559276 |
0.177 |
|
| 2004 |
Kelber O, Storr M, Sibaev A, Weiser D, Kudo T, Nagata S, Aoyagi Y, Suzuki R, Matsuda H, Ohtsuka Y, Shimizu T, Okumura K, Yamashiro Y, Størdal K, Jahnsen J, et al. Contents Vol. 70, 2004 Digestion. 70: 271-272. DOI: 10.1159/000084582 |
0.175 |
|
| 2015 |
Zoller V, Storr M, Göke B, Buch T, Da Costa O, Laguna A. Fäkaler Mikrobiom-Transfer (FMT) bei therapierefraktärem Diarrhoe-betontem Reizdarmsyndrom Zeitschrift FüR Gastroenterologie. 53. DOI: 10.1055/S-0035-1559280 |
0.173 |
|
| 2014 |
Chen C, Fichna J, Laudon M, Storr M. Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain. World Journal of Gastroenterology : Wjg. 20: 1298-304. PMID 24574803 DOI: 10.3748/wjg.v20.i5.1298 |
0.169 |
|
| 2000 |
Storr M, Geisler F, Neuhuber WL, Schusdziarra V, Allescher HD. Endomorphin-1 and -2, endogenous ligands for the mu-opioid receptor, inhibit striated and smooth muscle contraction in the rat oesophagus. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 12: 441-8. PMID 11012944 |
0.168 |
|
| 2004 |
Kelber O, Storr M, Sibaev A, Weiser D, Kudo T, Nagata S, Aoyagi Y, Suzuki R, Matsuda H, Ohtsuka Y, Shimizu T, Okumura K, Yamashiro Y, Størdal K, Jahnsen J, et al. Subject Index Vol. 70, 2004 Digestion. 70: 269-270. DOI: 10.1159/000084581 |
0.166 |
|
| 2011 |
Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: epidemiology, clinical features, and current management. Therapeutic Advances in Gastroenterology. 4: 301-9. PMID 21922029 DOI: 10.1177/1756283X10392443 |
0.164 |
|
| 1999 |
Storr M, Allescher HD. Esophageal pharmacology and treatment of primary motility disorders. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 12: 241-57. PMID 10770358 |
0.158 |
|
| 2015 |
Mosińska P, Fichna J, Storr M. Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation. World Journal of Gastroenterology. 21: 7436-42. PMID 26139989 DOI: 10.3748/wjg.v21.i24.7436 |
0.158 |
|
| 2013 |
Fichna J, Wood JT, Papanastasiou M, Vadivel SK, Oprocha P, Sałaga M, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Krajewska WM, Kościelniak P, Makriyannis A, Storr MA. Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study. Plos One. 8: e85073. PMID 24386448 DOI: 10.1371/Journal.Pone.0085073 |
0.157 |
|
| 2014 |
Alfadda AA, Shaffer EA, Urbanski SJ, Storr MA. Eosinophilic colitis is a sporadic self-limited disease of middle-aged people: a population-based study. Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland. 16: 123-9. PMID 24138295 DOI: 10.1111/codi.12464 |
0.157 |
|
| 2011 |
Storr M. [Therapy of gastroesophageal reflux disease (GERD)]. Medizinische Monatsschrift Fã¼R Pharmazeuten. 34: 446-54; quiz 455-6. PMID 22233024 |
0.155 |
|
| 2021 |
Krammer H, Storr M, Madisch A, Riffel J. [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]. Zeitschrift Fur Gastroenterologie. 59: 125-134. PMID 33556972 DOI: 10.1055/a-1340-0204 |
0.151 |
|
| 2015 |
Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Current Drug Targets. 16: 181-8. PMID 25642719 |
0.144 |
|
| 2013 |
Fullhase C, Campeau L, Sibaev A, Storr M, Gratzke C, Stief C, Hedlund P, Andersson K. 447 Micturition is controlled by neuronal cannabinoid receptor type 1 – a urodynamic evaluation of a CB1 knockout mouse model European Urology Supplements. 12: e447. DOI: 10.1016/S1569-9056(13)60931-8 |
0.142 |
|
| 2010 |
Papay KD, Falck VG, Poulsen SS, Panaccione R, Rehfeld JF, Storr MA. Juvenile polyposis of the stomach--a novel cause of hypergastrinemia. Nature Reviews. Gastroenterology & Hepatology. 7: 583-8. PMID 20808292 DOI: 10.1038/nrgastro.2010.138 |
0.141 |
|
| 2012 |
Storr M. Chronic inflammatory bowel disease: Certolizumab pegol induces remission of Crohn's disease in patients with elevated CRP | Chronisch entzündliche darmerkrankungen: Certolizumab pegol induziert bei morbus-Crohn-patienten mit erhöhtem CRP eine remission Medizinische Monatsschrift Fur Pharmazeuten. 35. |
0.139 |
|
| 2014 |
Bashashati M, Hejazi RA, Andrews CN, Storr MA. Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia? Canadian Journal of Gastroenterology & Hepatology. 28: 335-41. PMID 24719900 DOI: 10.1155/2014/904707 |
0.139 |
|
| 2013 |
Storr M. [Functional heartburn--update 2013]. Mmw Fortschritte Der Medizin. 155: 100-3. PMID 24934062 |
0.138 |
|
| 2014 |
Storr M. Vedolizumab in inflammatory bowel diseases | Vedolizumab bei chronischentziindlichen Darmerkrankungen Arzneimitteltherapie. 32: 618-627. |
0.138 |
|
| 2011 |
Storr MA. What is nonacid reflux disease? Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 25: 35-8. PMID 21258666 |
0.138 |
|
| 2018 |
Grill M, Hasenoehrl C, Storr M, Schicho R. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon? Medical Cannabis and Cannabinoids. 1: 28-35. DOI: 10.1159/000489036 |
0.137 |
|
| 2003 |
Storr M, Allescher HD. [Diseases of gastrointestinal motility. Treatment with motility-modifying substances]. Medizinische Monatsschrift Fã¼R Pharmazeuten. 26: 260-9. PMID 12953379 |
0.136 |
|
| 2014 |
Storr M. Chronic inflammatory bowel diseases: Is cannabis helpful in the treatment of Crohn's disease? | Cannabis hilfreich in der therapie des Morbus Crohn? Medizinische Monatsschrift Fur Pharmazeuten. 37: 144-145. |
0.134 |
|
| 2016 |
Waggershauser CH, Storr M. [Lower gastrointestinal bleeding]. Mmw Fortschritte Der Medizin. 158: 50-2. PMID 27155708 DOI: 10.1007/s15006-016-8208-y |
0.134 |
|
| 2012 |
Fichna J, Storr MA. Brain-Gut Interactions in IBS. Frontiers in Pharmacology. 3: 127. PMID 22783191 DOI: 10.3389/fphar.2012.00127 |
0.132 |
|
| 1998 |
Huber A, Trudrung P, Storr M, Franck H, Schusdziarra V, Ruth P, Allescher HD. Protein kinase G expression in the small intestine and functional importance for smooth muscle relaxation. American Journal of Physiology. Gastrointestinal and Liver Physiology. 275: G629-G637. PMID 29591787 DOI: 10.1152/ajpgi.1998.275.4.G629 |
0.132 |
|
| 2021 |
Storr M, Gross M, Madisch A, von Arnim U, Mönnikes H, Walters J, Krammer H, Keller J. [Bile acid diarrhea, stepchild of chronic diarrhea - prevalence, diagnosis and treatment. Update 2021]. Zeitschrift Fur Gastroenterologie. PMID 33634438 DOI: 10.1055/a-1378-9627 |
0.129 |
|
| 2002 |
Hahn A, Storr M, Allescher HD. Effect of tachykinins on ascending and descending reflex pathway in rat small intestine. Acta Pharmacologica Sinica. 23: 289-95. PMID 11931700 |
0.126 |
|
| 2014 |
Storr M. Rifaximin is safe in the treatment of irritable bowel syndrome without constipation | Rifaximin ist sicher in der Behandlung des Reizdarmsyndroms ohne Obstipation Medizinische Monatsschrift Fur Pharmazeuten. 37: 471-472. |
0.125 |
|
| 2001 |
Storr M, Allescher HD, Rösch T, Born P, Weigert N, Classen M. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointestinal Endoscopy. 54: 754-9. PMID 11726856 |
0.121 |
|
| 2022 |
Storr M. Reizdarm: Selbst potenziell letale Therapien wären willkommen. Mmw Fortschritte Der Medizin. 164: 26-27. PMID 36123469 DOI: 10.1007/s15006-022-1825-8 |
0.12 |
|
| 2021 |
Storr M. Mmw Fortschritte Der Medizin. 163: 30. PMID 34533719 DOI: 10.1007/s15006-021-0350-5 |
0.12 |
|
| 2021 |
Storr M. Mmw Fortschritte Der Medizin. 163: 28-29. PMID 33638834 DOI: 10.1007/s15006-021-9685-1 |
0.12 |
|
| 2020 |
Storr M. Mmw Fortschritte Der Medizin. 162: 26-27. PMID 33074494 DOI: 10.1007/s15006-020-4457-x |
0.12 |
|
| 2014 |
Storr M. Irritable bowel syndrome: Rifaximin is safe in the treatment of irritable bowel syndrome without constipation | Reizdarmsyndrom: Rifaximin ist sicher in der Beliandlung des Reizdarmsyndroms ohne Obstipation Arzneimitteltherapie. 32: 385-386. |
0.118 |
|
| 2012 |
Fichna J, Lapointe T, Chapman K, Janecka A, Vergnolle N, Altier C, Storr MA. New neostigmine-based behavioral mouse model of abdominal pain. Pharmacological Reports : Pr. 64: 1146-54. PMID 23238471 |
0.118 |
|
| 2010 |
Williams JJ, Beck PL, Andrews CN, Hogan DB, Storr MA. Microscopic colitis -- a common cause of diarrhoea in older adults. Age and Ageing. 39: 162-8. PMID 20065357 DOI: 10.1093/ageing/afp243 |
0.114 |
|
| 2022 |
Storr M, Weigmann H, Landes S, Michel MC. Self-Medication for the Treatment of Abdominal Cramps and Pain-A Real-Life Comparison of Three Frequently Used Preparations. Journal of Clinical Medicine. 11. PMID 36362589 DOI: 10.3390/jcm11216361 |
0.113 |
|
| 1998 |
Franck H, Storr M, Puschmann A, Schusdziarra V, Allescher HD. Involvement of intracellular Castores in inhibitory effects of NO donor SIN-1 and cGMP. American Journal of Physiology. Gastrointestinal and Liver Physiology. 275: G159-G168. PMID 29585152 DOI: 10.1152/ajpgi.1998.275.1.G159 |
0.113 |
|
| 2013 |
Storr M. [Helicobacter pylori - Update 2013]. Medizinische Monatsschrift Fã¼R Pharmazeuten. 36: 172-6; quiz 177-8. PMID 23758027 |
0.113 |
|
| 2012 |
Fiedler R, Neugebauer F, Ulrich C, Wienke A, Gromann C, Storr M, Böhler T, Seibert E, Girndt M. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein. Artificial Organs. 36: 886-93. PMID 22845695 DOI: 10.1111/j.1525-1594.2012.01479.x |
0.112 |
|
| 2015 |
Atan R, May C, Bailey SR, Tanudji M, Visvanathan K, Skinner N, Bellomo R, Goehl H, Storr M. Nucleosome levels and toll-like receptor expression during high cut-off haemofiltration: a pilot assessment. Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine. 17: 239-43. PMID 26640058 |
0.112 |
|
| 2015 |
Storr M. Teduglutide is the first drug for the specific treatment of short bowel syndrome | Teduglutid ist das erste Arzneimittel zur spezifischen Behandlung des Kurzdarmsyndroms Arzneimitteltherapie. 33: 154-155. |
0.108 |
|
| 2015 |
Girndt M, Fiedler R, Martus P, Pawlak M, Storr M, Boehler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Zickler D, Schindler R. High cut-off dialysis in chronic hemodialysis patients. European Journal of Clinical Investigation. PMID 26519693 DOI: 10.1111/eci.12559 |
0.108 |
|
| 2013 |
Klein S, Seidler B, Kettenberger A, Sibaev A, Rohn M, Feil R, Allescher HD, Vanderwinden JM, Hofmann F, Schemann M, Rad R, Storr MA, Schmid RM, Schneider G, Saur D. Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activity. Nature Communications. 4: 1630. PMID 23535651 DOI: 10.1038/ncomms2626 |
0.108 |
|
| 2008 |
Müller M, Gong Q, Sibaev A, Vinson B, Weiser D, Kelber O, Storr M, Yongyu L, Kreis M. Influence of a herbal fixed combination preparation on intestinal afferent nerve sensitivity in a pharmacological in vivo model Zeitschrift FüR Phytotherapie. 29. DOI: 10.1055/s-2008-1047871 |
0.106 |
|
| 2014 |
Meijers B, Maas RJ, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JK, Dietrich R, Storr M, Wetzels JF, Evenepoel P, Kuypers D. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney International. 85: 636-40. PMID 24402090 DOI: 10.1038/ki.2013.505 |
0.105 |
|
| 2012 |
Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, Kaplan GG, Vogel HJ, Storr M. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. Journal of Proteome Research. 11: 3344-57. PMID 22574726 DOI: 10.1021/Pr300139Q |
0.104 |
|
| 2015 |
Meijers B, Poesen R, Claes K, Dietrich R, Bammens B, Sprangers B, Naesens M, Storr M, Kuypers D, Evenepoel P. Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease. Kidney International. 87: 210-6. PMID 24897037 DOI: 10.1038/ki.2014.197 |
0.101 |
|
| 2015 |
Storr M. Irritable bowel syndrome: Pinaverium relieves abdominal pain | Reizdarmsyndrom: Pinaverium lindert abdominelle Schmerzen Arzneimitteltherapie. 33: 242-243. |
0.101 |
|
| 2021 |
Storr M, Stengel A. [Systematic review: clinical evidence of probiotics in the prevention of antibiotic-associated diarrhoea]. Mmw Fortschritte Der Medizin. 163: 19-26. PMID 33844181 DOI: 10.1007/s15006-021-9762-5 |
0.101 |
|
| 2008 |
Storr M, Yuece B, Wallbach J, Sibaev A, Weiser D, Kelber O. Back to the roots? Herbal extracts modulate peristaltic reflex of rat small intestine Zeitschrift FüR Phytotherapie. 29. DOI: 10.1055/s-2008-1047879 |
0.1 |
|
| 2014 |
Storr M. Therapeutic indications: Collagenous colitis: The locally effective budesonide is superior to mesalazine and placebo | Therapiehinweise: Kollagene Kolitis: Das lokal wirksame Budesonid ist Mesalazin und Plazebo überlegen Arzneimitteltherapie. 32: 384-385. |
0.099 |
|
| 1996 |
Clarke D, Johnson PW, Banks RE, Storr M, Kinsey SE, Johnson R, Morgan G, Gordon MY, Illingworth JM, Perren TJ, Selby PJ. Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine. 8: 717-23. PMID 8932983 DOI: 10.1006/cyto.1996.0095 |
0.099 |
|
| 2012 |
Storr M. Irritable bowel syndrome without constipation: Two-week treatment with rifaximin relieves the symptoms over several weeks | Reizdarmsyndrom ohne obstipation: Zweiwöchige therapie mit rifaximin lindert die symptome über mehrere wochen Medizinische Monatsschrift Fur Pharmazeuten. 35. |
0.098 |
|
| 2000 |
Banks RE, Forbes MA, Patel PM, Storr M, Hallam S, Clarke D, Novick D, Ingham E, Bowmer C, Southgate J, Trejdosiewicz LK, Illingworth J, Perren TJ, Selby PJ. Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects. Cytokine. 12: 388-96. PMID 10805221 DOI: 10.1006/cyto.1999.0556 |
0.096 |
|
| 2013 |
Klein S, Seidler B, Kettenberger A, Sibaev A, Rohn M, Feil R, Allescher H, Vanderwinden J, Hofmann F, Schemann M, Rad R, Storr MA, Schmid RM, Schneider G, Saur D. Interstitial cells of Cajal link excitatory and nitrergic inhibitory neurotransmission with slow-wave activity in the intestine Bmc Pharmacology and Toxicology. 14. DOI: 10.1186/2050-6511-14-S1-O30 |
0.096 |
|
| 2014 |
Storr M. [Irritable bowel syndrome - diet modifies the symptoms]. Mmw Fortschritte Der Medizin. 156: 33. PMID 24908882 |
0.095 |
|
| 2013 |
Storr M. [Short bowel syndrome. GLP-2 analog teduglutide]. Medizinische Monatsschrift Fã¼R Pharmazeuten. 36: 343-5. PMID 24069647 |
0.094 |
|
| 2021 |
Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, Tack J, Accarino A, Barbara G, Bor S, Coffin B, Corsetti M, De Schepper H, Dumitrascu D, ... ... Storr M, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 33: e14238. PMID 34586707 DOI: 10.1111/nmo.14238 |
0.094 |
|
| 2021 |
Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, Tack J, Accarino A, Barbara G, Bor S, Coffin B, Corsetti M, De Schepper H, Dumitrascu D, ... ... Storr M, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterology Journal. 9: 307-331. PMID 33939891 DOI: 10.1002/ueg2.12061 |
0.094 |
|
| 2014 |
Storr M. Men with diarrhea-predominant irritable bowel syndrome: Ramosetron improves stool consistency | Männer mit diarrhö-betontem reizdarmsyndrom: Ramosetron verbessert die stuhlkonsistenz Arzneimitteltherapie. 32: 138-139. |
0.093 |
|
| 2016 |
Storr M. [A new remedy for diarrheal irritable bowel syndrome]. Mmw Fortschritte Der Medizin. 158: 43. PMID 26979218 DOI: 10.1007/s15006-016-7937-2 |
0.093 |
|
| 2012 |
Storr M. Gastroesophageal reflux disease: The reflux inhibitors baclofen and lesogaberan fail in the clinical trial | Gastroösophageale refluxkrankheit: Die refluxinhibitoren baclofen und lesogaberan enttäuschen in der klinischen prüfung Medizinische Monatsschrift Fur Pharmazeuten. 35. |
0.093 |
|
| 2022 |
Ueberall MA, Essner U, Müller-Schwefe G, Horlemann J, Storr M. Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry. Current Medical Research and Opinion. 38: 101-114. PMID 34617483 DOI: 10.1080/03007995.2021.1990032 |
0.092 |
|
| 2022 |
Storr M. [Disturbed intestinal barrier: What specifically does the family doctor need to know and how and when should he act?] Mmw Fortschritte Der Medizin. 164: 54-58. PMID 35332492 DOI: 10.1007/s15006-022-0833-z |
0.09 |
|
| 2001 |
Koppitz PB, Storr MA, Kurjak M, Allescher H. Evidence for regulatory role of bilirubin on NO-mediated responses in the enteric nervous system of rat Gastroenterology. 120: A176. DOI: 10.1016/S0016-5085(08)80870-0 |
0.089 |
|
| 2015 |
Storr M. [Antidepressants for esophageal diseases?]. Mmw Fortschritte Der Medizin. 157: 36. PMID 26019090 DOI: 10.1007/s15006-015-3130-2 |
0.089 |
|
| 2023 |
Stallmach A, von Müller L, Storr M, Link A, Konturek PC, Solbach PC, Weiss KH, Wahler S, Vehreschild MJGT. [Fecal Microbiota Transfer (FMT) in Germany - Status and Perspective]. Zeitschrift Fur Gastroenterologie. PMID 37187187 DOI: 10.1055/a-2075-2725 |
0.088 |
|
| 2015 |
Jewson JL, Lambert GW, Storr M, Gaida JE. The sympathetic nervous system and tendinopathy: a systematic review. Sports Medicine (Auckland, N.Z.). 45: 727-43. PMID 25655371 DOI: 10.1007/s40279-014-0300-9 |
0.087 |
|
| 2014 |
Storr M. Ulcerative colitis: Infliximab-azathioprine combination therapy is superior to monotherapies | Colitis ulcerosa: Infliximab-Azathioprin-Kombinationstherapie ist den Monotherapien überlegen Arzneimitteltherapie. 32: 387-388. |
0.085 |
|
| 1996 |
Bertsch T, Banks RE, Forbes MA, Aufenanger J, Storr M, Illingworth JM, Perren TJ, Selby PJ, Kattermann R. Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancer. Annals of Clinical Biochemistry. 33: 565-7. PMID 8937592 |
0.079 |
|
| 2022 |
Storr M, Stracke B. Menthacarin for long-term treatment of functional dyspepsia - Results from a clinical trial follow-up. Zeitschrift Fur Gastroenterologie. PMID 35697065 DOI: 10.1055/a-1823-1333 |
0.078 |
|
| 2016 |
Sibaev A, Pumnea T, Lipowicz B, Storr M. Multimodale Wirkung der Einzelkomponenten von Myrrhinil-Intest® auf die intestinale Neurotransmission und Motilität in vitro Zeitschrift FüR Gastroenterologie. 54. DOI: 10.1055/s-0036-1587119 |
0.078 |
|
| 2021 |
Bestfater C, Vehreschild MJGT, Stallmach A, Tüffers K, Erhardt A, Frank T, Glück T, Goeser F, Sellge G, Solbach P, Eisenlohr H, Storr M. Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infections. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 33744169 DOI: 10.1016/j.dld.2021.02.022 |
0.077 |
|
| 2021 |
Gross M, Storr M. [Bile acid diarrhoea: a frequent cause of unexplained diarrhea]. Mmw Fortschritte Der Medizin. 163: 46-47. PMID 33783797 DOI: 10.1007/s15006-021-9660-x |
0.077 |
|
| 2012 |
Storr M. Chronic constipation: The guanylate cyclase activator linaclotide relieves the symptoms | Chronische obstipation: Der guanylatcyclase-aktivator linaclotid lindert die symptome Medizinische Monatsschrift Fur Pharmazeuten. 35. |
0.076 |
|
| 2015 |
Storr M. [In diarrhea of unknown origin also think of olmesartan!]. Mmw Fortschritte Der Medizin. 157: 34. PMID 25743974 DOI: 10.1007/s15006-015-2764-4 |
0.076 |
|
| 2017 |
Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, ... ... Storr MA, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterology Journal. 5: 335-358. PMID 28507746 DOI: 10.1177/2050640616689525 |
0.075 |
|
| 2007 |
Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. Journal of the American Society of Nephrology : Jasn. 18: 886-95. PMID 17229909 DOI: 10.1681/ASN.2006080821 |
0.073 |
|
| 2001 |
Storr M, Weigert N, Weiss W, Allescher HD, Berger H. [Hemosuccus pancreaticus (bleeding into the pancreatic duct). A rare complication of pancreatitis]. Deutsche Medizinische Wochenschrift (1946). 126: 108-12. PMID 11225385 DOI: 10.1055/s-2001-10867 |
0.073 |
|
| 1995 |
Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, Illingworth JM, Perren TJ, Selby PJ, Whicher JT. The acute phase protein response in patients receiving subcutaneous IL-6. Clinical and Experimental Immunology. 102: 217-23. PMID 7554393 |
0.072 |
|
| 2014 |
Storr M, Starostzik C. [Stool transplantation: also an option for irritable bowel syndrome?]. Mmw Fortschritte Der Medizin. 156: 16. PMID 25369668 |
0.071 |
|
| 2013 |
Storr M. Eosinophilic esophagitis: Improvement by swallowed nebulized fluticasone and esomeprazole | Eosinophile ösophagitis: Verbesserung durch geschlucktes vernebeltes fluticason und esomeprazol Arzneimitteltherapie. 31: 174-175. |
0.07 |
|
| 2012 |
Storr M. Functional dyspepsia: Acotiamide relieves postprandial dyspeptic symptoms | Funktionelle dyspepsie: Acotiamid lindert postprandiale dyspeptische beschwerden Medizinische Monatsschrift Fur Pharmazeuten. 35. |
0.069 |
|
| 2004 |
Gündel H, Storr M. [Irritable bowel syndrome: the challenge to psychosomatic and internal medical specialists to collaborate closely]. Mmw Fortschritte Der Medizin. 146: 24, 26-8. PMID 15540555 |
0.068 |
|
| 2013 |
Stewart MJ, Shaffer E, Urbanski SJ, Beck PL, Storr MA. The association between celiac disease and eosinophilic esophagitis in children and adults. Bmc Gastroenterology. 13: 96. PMID 23721294 DOI: 10.1186/1471-230X-13-96 |
0.068 |
|
| 2001 |
Koppitz PB, Storr MA, Saur D, Kurjak M, Allescher H. Inhibitory effect of melatonin on nitric oxide synthase in rat enteric nervous system Gastroenterology. 120: A176. DOI: 10.1016/S0016-5085(08)80869-4 |
0.068 |
|
| 2014 |
Storr M. [Ulcerative colitis: Infliximab-Azathioprine combination therapy is superior to monotherapy]. Medizinische Monatsschrift Fã¼R Pharmazeuten. 37: 470-1. PMID 25643453 |
0.067 |
|
| 2003 |
Storr M, Born P, Frimberger E, Weigert N, Rösch T, Meining A, Classen M, Allescher H. Erratum to: Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment Bmc Gastroenterology. 3. DOI: 10.1186/1471-230X-3-32 |
0.067 |
|
| 2014 |
Krieter DH, Devine E, Wanner C, Storr M, Krause B, Lemke HD. Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysis. Artificial Organs. 38: 888-93. PMID 24392952 DOI: 10.1111/aor.12248 |
0.066 |
|
| 2013 |
Storr M. Eosinophilic esophagitis: Improvement through aerosolized swallowed fluticasone and esomeprazole | Eosinophile ösophagitis: Verbesserung durch geschlucktes vernebeltes Fluticason und Esomeprazol Medizinische Monatsschrift Fur Pharmazeuten. 36: 270-272. |
0.065 |
|
| 2014 |
Storr M. [How to proceed when the pathologist does not confirm suspected Barrett esophagus?]. Mmw Fortschritte Der Medizin. 156: 33. PMID 24930224 |
0.061 |
|
| 2013 |
Sibaev A, Abdel-Aziz H, Kelber O, Weiser D, Göke B, Storr M. Entzündungsinduzierte akute gastrointestinale Hyperkontraktilität wird von STW 5 und seinen pflanzlichen Einzelkomponenten in vitro gehemmt Zeitschrift FüR Phytotherapie. 34. DOI: 10.1055/s-0033-1338230 |
0.06 |
|
| 2015 |
Storr M. [A second opiate poisoning often follow the first one]. Mmw Fortschritte Der Medizin. 157: 35. PMID 25743512 DOI: 10.1007/s15006-015-2638-9 |
0.059 |
|
| 2004 |
Storr MT, Taylor PC, Monfort JP, Rodger PM. Kinetic inhibitor of hydrate crystallization. Journal of the American Chemical Society. 126: 1569-76. PMID 14759217 DOI: 10.1021/ja035243g |
0.058 |
|
| 2014 |
Atan R, Virzi GM, Peck L, Ramadas A, Brocca A, Eastwood G, Sood S, Ronco C, Bellomo R, Goehl H, Storr M. High cut-off hemofiltration versus standard hemofiltration: a pilot assessment of effects on indices of apoptosis. Blood Purification. 37: 296-303. PMID 25096908 DOI: 10.1159/000363220 |
0.057 |
|
| 2024 |
Storr M. [What to do with cough, dysphonia, hoarseness and scratching throat?]. Mmw Fortschritte Der Medizin. 166: 52-53. PMID 38261208 DOI: 10.1007/s15006-023-3503-x |
0.057 |
|
| 2002 |
Allescher HD, Storr M. [Botulinum toxin: indications in internal medicine]. Der Internist. 43: 1566-74. PMID 12607396 DOI: 10.1007/s00108-002-0754-y |
0.057 |
|
| 2014 |
Storr M. The locally effective budesonide is superior to mesalazine and placebo | Das lokal wirksame Budesonid ist Mesalazin und Plazebo überlegen Medizinische Monatsschrift Fur Pharmazeuten. 37: 468-469. |
0.056 |
|
| 2008 |
Hutchison CA, Harding S, Mead G, Goehl H, Storr M, Bradwell A, Cockwell P. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artificial Organs. 32: 910-7. PMID 19133018 DOI: 10.1111/j.1525-1594.2008.00653.x |
0.056 |
|
| 2013 |
Storr MA. Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013. Isrn Gastroenterology. 2013: 352718. PMID 23691336 DOI: 10.1155/2013/352718 |
0.056 |
|
| 2014 |
Peltekova I, Storr M. Case 1: Back pain in a boy with Duchenne muscular dystrophy. Paediatrics & Child Health. 19: 299-300. PMID 25332657 |
0.055 |
|
| 2016 |
Jarmuż A, Banaszek M, Leń K, Storr M, Zielińska M, Fichna J. Dietary Fats and Oils in India. Current Diabetes Reviews. PMID 27501784 |
0.054 |
|
| 2008 |
Storr M. Letter 1: Functional results after extended myotomy for diffuse oesophageal spasm (Br J Surg 2007; 94: 1113-1118). The British Journal of Surgery. 95: 125; author reply 12. PMID 18161891 DOI: 10.1002/bjs.6116 |
0.054 |
|
| 2007 |
Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Davenport P, Morgera S, Goehl H, Storr M, Boyce N, Neumayer HH. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 50: 296-304. PMID 17660031 DOI: 10.1053/j.ajkd.2007.05.003 |
0.053 |
|
| 2013 |
Klein S, Seidler B, Kettenberger A, Sibaev A, Feil R, Hofmann F, Vanderwinden J, Allescher H, Schemann M, Storr MA, Schmid RM, Schneider G, Saur D. Interstitial cells of Cajal plasticity rather than regeneration restores slow-wave activity and enteric neurotransmission upon acute damage Bmc Pharmacology and Toxicology. 14. DOI: 10.1186/2050-6511-14-S1-P34 |
0.052 |
|
| 2013 |
Jaberzadeh S, Zoghi M, Morgan P, Storr M. Corticospinal Facilitation of Erector Spinae and Rectus Abdominis Muscles During Graded Voluntary Contractions is Task Specific: A Pilot Study on Healthy Individuals. Basic and Clinical Neuroscience. 4: 209-16. PMID 25337349 |
0.052 |
|
| 2015 |
Schmidt T, Storr M. Orale Eisengabe vor Guajaktest unbedenklich Mmw - Fortschritte Der Medizin. 157: 32-32. DOI: 10.1007/s15006-015-2691-4 |
0.051 |
|
| 2017 |
Storr M. Keine Hinweise auf Missbrauchspotenzial bei Opioidrezeptor-Modulator Gastro-News. 4: 16-17. DOI: 10.1007/s15036-017-0221-1 |
0.05 |
|
| 2015 |
Pumnea T, Lipowicz B, Storr M, Sibaev A. In-vitro Untersuchungen zur Wirkungsweise isolierter Komponenten aus Myrrhinil®-Intest auf die intestinale Neurotransmission und Motilität Zeitschrift FüR Gastroenterologie. 53. DOI: 10.1055/s-0035-1558905 |
0.049 |
|
| 2014 |
Peltekova I, Storr M. Case 1: Back pain in a boy with Duchenne muscular dystrophy - Acute myocardial injury Paediatrics and Child Health (Canada). 19: 299-300. |
0.048 |
|
| 2015 |
Storr M. [In acid reflux diet habits should be intensively discussed]. Mmw Fortschritte Der Medizin. 157: 26. PMID 25743290 DOI: 10.1007/s15006-015-2576-6 |
0.047 |
|
| 2015 |
Storr M. Der Ernährungsratgeber zur FODMAP-DIÄT: Die etwas andere Diät bei Reizdarm, Weizenunverträglichkeit und anderen Verdauungsstörungen Deutsche Zeitschrift FüR Akupunktur. 58: 53-54. DOI: 10.1016/S0415-6412(15)30083-7 |
0.047 |
|
| 2014 |
Keir R, Evans ND, Hutchison CA, Vigano MR, Stella A, Fabbrini P, Storr M, Chappell MJ. Kinetic modelling of haemodialysis removal of myoglobin in rhabdomyolysis patients. Computer Methods and Programs in Biomedicine. 114: e29-38. PMID 24008249 DOI: 10.1016/j.cmpb.2013.07.017 |
0.046 |
|
| 2019 |
Waggershauser CH, Storr M. IgG4-assoziierte Erkrankungen des Gastrointestinaltrakts Gastro-News. 6: 35-40. DOI: 10.1007/s15036-019-0599-z |
0.045 |
|
| 2011 |
Schmitz GL, Fassler NT, Fellows GM, Shirley AM, Chamblee RW, Finch CW, Storr MA, Vassalotti PM, Klingaman TD, Thomas WE, Rathmann DP. Arrested ear development in corn caused by a component Agronomy Journal. 103: 1697-1703. DOI: 10.2134/agronj2011.0048 |
0.045 |
|
| 2018 |
Storr M. Liegt seronegativer villöser Atrophie wirklich nur Zöliakie zugrunde? Gastro-News. 5: 10-11. DOI: 10.1007/s15036-018-0307-4 |
0.044 |
|
| 2000 |
Storr M, Allescher HD. [Motility-modifying drugs]. Der Internist. 41: 1318-24, 1326-30. PMID 11189067 |
0.044 |
|
| 2006 |
Yüce B, Wallbach J, Sibaev A, Kelber O, Vinson B, Schirra J, Göke B, Storr M. Der peristaltische Reflex am Dünndarm der Ratte wird durch STW 5 (Iberogast®) moduliert Zeitschrift FüR Phytotherapie. 27. DOI: 10.1055/s-2006-954936 |
0.044 |
|
| 2014 |
Storr M. [Diet improves symptoms of diabetic gastroparesis]. Mmw Fortschritte Der Medizin. 156: 36. PMID 25195403 DOI: 10.1007/s15006-014-3336-8 |
0.043 |
|
| 2018 |
Storr M. Neuer Wirkstoff lindert Obstipation und abdominelle Schmerzen Gastro-News. 5: 14-15. DOI: 10.1007/s15036-018-0409-z |
0.042 |
|
| 2019 |
Andrews CN, Devlin SM, Le Foll B, Fischer B, Tse F, Storr M, Congly SE. Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders. Journal of the Canadian Association of Gastroenterology. 2: 37-43. PMID 31294362 DOI: 10.1093/jcag/gwy064 |
0.041 |
|
| 2015 |
Storr M. Regorafenib for metastatic colorectal cancer (mCRC) and gastrointestinal stromal tumor (GIST) | Regorafenib beim metastasierten kolorektalen Karzinom (mCRC) und beim gastrointestinalen Stromatumor (GIST) Arzneimitteltherapie. 33: 15-17. |
0.041 |
|
| 2014 |
Storr M. [Sufficient sleep protects against ulcerative colitis]. Mmw Fortschritte Der Medizin. 156: 52. PMID 25608406 |
0.041 |
|
| 2014 |
Scott C, Robinson M, Kenny SD, Storr MT, Willets A. Modelling He migration and bubble formation in δ Pu Plutonium Futures: the Science 2014. 63-64. |
0.04 |
|
| 2006 |
Allescher H, Storr M. Grundlagen und klinische Bedeutung der Multikanal intraluminale Impedanz - MII für die Funktionsdiagnostik am Ösophagus Endoskopie Heute. 19: 228-234. DOI: 10.1055/s-2006-955210 |
0.04 |
|
| 2019 |
Storr M. Therapieempfehlungen bei funktioneller Dyspepsie Gastro-News. 6: 10-11. DOI: 10.1007/s15036-019-0588-2 |
0.04 |
|
| 2018 |
Storr M. Diagnostik und Beratung zu Ernährungsfragen beim Reizdarmsyndrom Gastro-News. 5: 34-41. DOI: 10.1007/s15036-018-0473-4 |
0.04 |
|
| 2018 |
Waggershauser CH, Storr M. Komplikationen und Konsequenzen der chronischen Pankreatitis Gastro-News. 5: 33-38. DOI: 10.1007/s15036-018-0353-y |
0.039 |
|
| 2014 |
Brincat NA, Parker SC, Molinari M, Allen GC, Storr MT. Ab initio investigation of the UO3 polymorphs: structural properties and thermodynamic stability. Inorganic Chemistry. 53: 12253-64. PMID 25405569 DOI: 10.1021/Ic500791M |
0.038 |
|
| 2009 |
Yüce B, Sibaev A, Kelber O, Raab M, Göke B, Müller M, Kreis M, Storr M. Kaempferol – ein Flavonol aus dem Extrakt von Iberis amara (STW 6) in Iberogast®– und der Gesamtextrakt hemmen elektrisch induzierte Kontraktionen des Ileums und modulieren elektrophysiologische Parameter im proximalen Kolon der Maus Zeitschrift FüR Phytotherapie. 30. DOI: 10.1055/s-0029-1239936 |
0.038 |
|
| 2022 |
Keller J, Wedel T, Seidl H, Kreis ME, van der Voort I, Gebhard M, Langhorst J, Lynen Jansen P, Schwandner O, Storr M, van Leeuwen P, Andresen V, Preiß JC, Layer P, Allescher H, et al. Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Zeitschrift Fur Gastroenterologie. 60: 192-218. PMID 35148561 DOI: 10.1055/a-1646-1279 |
0.037 |
|
| 2017 |
Storr M. Refluxerkrankung — Haben wir es uns zu bequem gemacht? Gastro-News. 4: 3-3. DOI: 10.1007/s15036-017-0263-4 |
0.037 |
|
| 2015 |
Brincat NA, Parker SC, Molinari M, Allen GC, Storr MT. Density functional theory investigation of the layered uranium oxides U3O8 and U2O5. Dalton Transactions (Cambridge, England : 2003). 44: 2613-22. PMID 25382599 DOI: 10.1039/C4Dt02493A |
0.037 |
|
| 2016 |
Müller J, Vinson B, Rabini S, Kelber O, Storr M, Kraft K. STW 5: Metaanalyse bestätigt Wirksamkeit und Studienqualität Zeitschrift FüR Phytotherapie. 37. DOI: 10.1055/s-0036-1584452 |
0.037 |
|
| 2015 |
Storr M. [Prolonged PPI therapy in reflux esophagitis is sustainable]. Mmw Fortschritte Der Medizin. 157: 35. PMID 26049345 DOI: 10.1007/s15006-015-3213-0 |
0.037 |
|
| 1973 |
Durakovic AB, Hollins JG, Storr MC. The influence of age and sex on the metabolism of americium by rats. Health Physics. 24: 541-6. PMID 4707669 |
0.036 |
|
| 2001 |
Storr M, Becker I, Huber W, Hohenleutner U, Lersch C. Septischer Verlauf einer erworbenen reaktiv perforierenden Kollagenose durch Superinfektion der Hautläsionen Intensivmedizin Und Notfallmedizin. 38: 570-575. DOI: 10.1007/S003900170033 |
0.036 |
|
| 2016 |
Storr M. Die Glutensensitivität gibt es wirklich PäDiatrie: Kinder- Und Jugendmedizin Hautnah. 28: 13-13. DOI: 10.1007/s15014-016-0651-9 |
0.035 |
|
| 2015 |
Storr M. [Donor stool now available in capsules]. Mmw Fortschritte Der Medizin. 157: 32. PMID 26012983 DOI: 10.1007/s15006-015-2865-0 |
0.035 |
|
| 2016 |
Storr M. Larazotide as option in case of failure of a gluten-free diet | Larazotid als option bei versagen einer glutenfreien diät Medizinische Monatsschrift Fur Pharmazeuten. 39: 89-90. |
0.034 |
|
| 2015 |
Brincat NA, Molinari M, Parker SC, Allen GC, Storr MT. Computer simulation of defect clusters in UO2 and their dependence on composition Journal of Nuclear Materials. 456: 329-333. DOI: 10.1016/J.Jnucmat.2014.10.001 |
0.034 |
|
| 2017 |
Lucendo AJ, Molina-Infante J, Arias Á, Von Arnim U, Bredenoord AJ, Bussmann C, Dias JA, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, ... ... Storr MA, et al. Wytyczne dotyczące rozpoznawania i postępowania w eozynofilowym zapaleniu przełyku u dzieci i dorosłych: oparte na faktach stwierdzenia i rekomendacje Gastroenterologia Praktyczna. 9: 6. DOI: 10.26625/gp.2017.9.2.35 |
0.032 |
|
| 2015 |
Brincat NA, Molinari M, Allen GC, Storr MT, Parker SC. Density functional theory calculations of defective UO2 at U3O7 stoichiometry Journal of Nuclear Materials. 467: 724-729. DOI: 10.1016/J.Jnucmat.2015.10.006 |
0.032 |
|
| 2010 |
Rehbein W, Schulze HP, Storr M. Influence of additives in dielectric fluids for electrical discharge machining 16th International Symposium On Electromachining, Isem 2010. 53-57. |
0.032 |
|
| 2016 |
Waggershauser CH, Storr M. [Halitosis and bad breath]. Mmw Fortschritte Der Medizin. 158: 43-6. PMID 27324003 DOI: 10.1007/s15006-016-8444-1 |
0.032 |
|
| 2018 |
Storr M. Welche Maßnahmen die Kollegen empfehlen Gastro-News. 5: 10-11. DOI: 10.1007/s15036-018-0493-0 |
0.031 |
|
| 2013 |
Haberfelner F, Kutsarov I, Maier T, Storr M. The Return Potential of UCITS Funds of Hedge Funds: An Analysis of their Investment Universe Reconsidering Funds of Hedge Funds. 113-134. DOI: 10.1016/B978-0-12-401699-6.00008-3 |
0.031 |
|
| 2019 |
Storr M. Ist das Ansprechen auf die FODMAP-Diät vorherzusagen? Gastro-News. 6: 18-19. DOI: 10.1007/s15036-019-0628-y |
0.031 |
|
| 1975 |
Hollins JG, Storr MC. An analysis of the retention of plutonium by the tissues of the rat. Radiation Research. 61: 468-77. PMID 1114266 |
0.031 |
|
| 2008 |
Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Storr M, Krause B, Boyce N, Svobodova S, Li W, Bagshaw SM, Warrillow S, Langenberg C, Morgera S. The effect of three different miniaturized blood purification devices on plasma cytokine concentration in an ex vivo model of endotoxinemia. The International Journal of Artificial Organs. 31: 722-9. PMID 18825645 |
0.031 |
|
| 2006 |
Ulsenheimer A, Schirra J, Göke B, Storr M. Enterothorax mimicking pleural effusion. Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology. 25: 146. PMID 16877829 |
0.031 |
|
| 2012 |
Robinson M, Kenny SD, Smith R, Storr MT. Point defect formation and migration in Ga stabilised δ-Pu Journal of Nuclear Materials. 423: 16-21. DOI: 10.1016/j.jnucmat.2011.11.046 |
0.03 |
|
| 2024 |
Storr M. [Not Available]. Mmw Fortschritte Der Medizin. 166: 26-27. PMID 38261193 DOI: 10.1007/s15006-024-3572-5 |
0.029 |
|
| 2016 |
Storr M. [Not Available]. Mmw Fortschritte Der Medizin. 158: 40. PMID 27119881 DOI: 10.1007/s15006-016-7873-1 |
0.029 |
|
| 2014 |
Storr M. [Smoking cessation improves reflux symptoms]. Mmw Fortschritte Der Medizin. 156: 30. PMID 24912259 DOI: 10.1007/s15006-014-2761-z |
0.029 |
|
| 2013 |
Maloney S, Storr M, Paynter S, Morgan P, Ilic D. Investigating the efficacy of practical skill teaching: a pilot-study comparing three educational methods. Advances in Health Sciences Education : Theory and Practice. 18: 71-80. PMID 22354336 DOI: 10.1007/s10459-012-9355-2 |
0.029 |
|
| 2015 |
Flitcroft JM, Molinari M, Brincat NA, Storr MT, Parker SC. Hydride ion formation in stoichiometric UO2. Chemical Communications (Cambridge, England). 51: 16209-12. PMID 26399168 DOI: 10.1039/C5Cc04799D |
0.028 |
|
| 2014 |
Storr M. [Fecal microbiome transfer helps in clostridium infections]. Mmw Fortschritte Der Medizin. 156: 35. PMID 25282930 DOI: 10.1007/s15006-014-3402-2 |
0.028 |
|
| 2016 |
Storr M. [Gluten sensitivity is real]. Mmw Fortschritte Der Medizin. 158: 38. PMID 27119689 DOI: 10.1007/s15006-016-7809-9 |
0.028 |
|
| 2013 |
Boschetti-de-Fierro A, Voigt M, Storr M, Krause B. Extended characterization of a new class of membranes for blood purification: the high cut-off membranes. The International Journal of Artificial Organs. 36: 455-63. PMID 23661558 DOI: 10.5301/ijao.5000220 |
0.027 |
|
| 2007 |
Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Morgera S, Goehl H, Storr M, Boyce N, Neumayer HH. Beta2-microglobulin removal and plasma albumin levels with high cut-off hemodialysis. The International Journal of Artificial Organs. 30: 385-92. PMID 17551901 |
0.027 |
|
| 2015 |
Lorkowski G, Kelber O, Abdel-Aziz H, Okpanyi S, Storr M, Nieber K. Mehrschrittiges Clustern von Daten am Beispiel der Multi-Target-Wirkung von STW 5 Zeitschrift FüR Phytotherapie. 36. DOI: 10.1055/s-0035-1565975 |
0.027 |
|
| 2018 |
Storr M. Gallensäure als Target bei Obstipation Gastro-News. 5: 14-15. DOI: 10.1007/s15036-018-0442-y |
0.026 |
|
| 2013 |
Maloney S, Storr M, Morgan P, Ilic D. The effect of student self-video of performance on clinical skill competency: a randomised controlled trial. Advances in Health Sciences Education : Theory and Practice. 18: 81-9. PMID 22354337 DOI: 10.1007/s10459-012-9356-1 |
0.026 |
|
| 2015 |
Madisch A, Vinson B, Abdel-Aziz H, Kelber O, Nieber K, Kraft K, Storr M. Regulatorische Einschränkungen bei den Gastroprokinetika: Die Phytotherapie als Therapie der Wahl bei funktionellen gastrointestinalen Erkrankungen Zeitschrift FüR Phytotherapie. 36. DOI: 10.1055/s-0035-1565935 |
0.025 |
|
| 2014 |
Storr M. Tests on fecal occult blood fail in the physician's everyday practice: Commentary | Tests auf okkultes blut im stuhl versagen im praxisalltag: Kommentar Mmw-Fortschritte Der Medizin. 156: 28. |
0.025 |
|
| 2006 |
Vogeser M, Hauer D, Christina Azad S, Huber E, Storr M, Schelling G. Release of anandamide from blood cells. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 44: 488-91. PMID 16599845 DOI: 10.1515/CCLM.2006.065 |
0.024 |
|
| 1975 |
Storr MC, Hollins JG, Clarke RL. An improved method of fission--fragment radiography of plutonium in rat bone. The International Journal of Applied Radiation and Isotopes. 26: 708-13. PMID 1201869 |
0.024 |
|
| 2015 |
Williams NR, Molinari M, Parker SC, Storr MT. Atomistic investigation of the structure and transport properties of tilt grain boundaries of UO2 Journal of Nuclear Materials. 458: 45-55. DOI: 10.1016/J.Jnucmat.2014.11.120 |
0.023 |
|
| 2013 |
Anand G, Kutsarov I, Maier T, Storr M. The influence of macroeconomic and behavioral factors on tactical strategy allocation (TSA) for funds of hedge funds Journal of Wealth Management. 16: 63-76. |
0.022 |
|
| 2014 |
Scott C, Kenny SD, Storr MT, Willets A. H diffusivity in Ga stabilised δ-Pu Plutonium Futures: the Science 2014. 195-196. |
0.022 |
|
| 2014 |
Flitcroft JM, Parker SC, Storr M, Molinari M. The structure and transport of H defects in UO2 Plutonium Futures: the Science 2014. 149. |
0.022 |
|
| 2011 |
Anand G, Maier T, Kutsarov I, Storr M. Importance of tactical strategy allocation on fund-of-hedge-funds allocations Journal of Wealth Management. 14: 49-58. DOI: 10.3905/jwm.2011.14.2.049 |
0.022 |
|
| 1973 |
Hollins JG, Durakovic A, Storr MC. The retention of americium and calcium by the skeleton of growing and mature female rats. Calcified Tissue Research. 12: 239-46. PMID 4747566 |
0.022 |
|
| 2014 |
Storr M. [High risk of relapse in opiate intoxication]. Mmw Fortschritte Der Medizin. 156: 32. PMID 24851439 |
0.021 |
|
| 1993 |
Tiltscher H, Storr M. Immobilization of the slime mould Dictyostelium discoideum for the continuous production of recombinant human antithrombin III. Applied Microbiology and Biotechnology. 40: 246-50. PMID 7764383 |
0.02 |
|
| 2014 |
Robinson M, Kenny SD, Smith R, Storr MT. He migration and bubble formation in Ga stabilised δ-Pu Journal of Nuclear Materials. 444: 493-500. DOI: 10.1016/j.jnucmat.2013.10.017 |
0.02 |
|
| 2014 |
Storr M. [Macrogol improved constipation, but not the quality of life]. Medizinische Monatsschrift Fã¼R Pharmazeuten. 37: 110-1. PMID 24741852 |
0.019 |
|
| 2019 |
Storr M, Waggershauser CH. Diagnostik und Therapie der chronischen Obstipation Gastro-News. 6: 30-38. DOI: 10.1007/s15036-019-0486-7 |
0.019 |
|
| 2011 |
Congly SE, Gao ZH, Storr M. Duodenal vascular ectasia (DUVE) associated with hematopoietic stem cell transplant. Endoscopy. 43: E197-8. PMID 21590601 DOI: 10.1055/s-0030-1256349 |
0.019 |
|
| 2010 |
Storr M, Speth J, Rehbein W, Schulze HP. A new additive and application system for wire-EDM 16th International Symposium On Electromachining, Isem 2010. 237-241. |
0.018 |
|
| 2009 |
Rehbein W, Schulze HP, Storr M. Influence of liquid additives in electro-erosive micromachining (EDMM) International Journal of Material Forming. 2: 661-664. DOI: 10.1007/s12289-009-0504-y |
0.018 |
|
| 2017 |
Storr M, Waggershauser CH. Pathophysiologie, Diagnostik und Therapie bei funktioneller Dyspepsie Gastro-News. 4: 40-47. DOI: 10.1007/s15036-017-0234-9 |
0.017 |
|
| 2005 |
Storr M, Allescher H. Endoskopisch-interventionelle Maßnahmen beim Zenker-Divertikel Verdauungskrankheiten. 23: 264-269. DOI: 10.5414/vdp23264 |
0.016 |
|
| 2015 |
Boschetti-De-Fierro A, Voigt M, Storr M, Krause B. MCO Membranes: Enhanced Selectivity in High-Flux Class Scientific Reports. 5. DOI: 10.1038/srep18448 |
0.015 |
|
| 2013 |
Scott C, Kenny SD, Storr MT, Willetts A. Modelling of dissolved H in Ga stabilised δ-Pu Journal of Nuclear Materials. 442: 83-89. DOI: 10.1016/j.jnucmat.2013.08.035 |
0.015 |
|
| 2013 |
Maloney S, Paynter S, Storr M, Morgan P. Implementing student self-video of performance. The Clinical Teacher. 10: 323-7. PMID 24015739 DOI: 10.1111/tct.12027 |
0.015 |
|
| 2019 |
Storr M. Defäkografie als Erstliniendiagnostikum? Gastro-News. 6: 23-24. DOI: 10.1007/s15036-019-0533-4 |
0.014 |
|
| 2014 |
Storr M. [Tests for occult blood in stool fail in routine practice]. Mmw Fortschritte Der Medizin. 156: 28. PMID 25369677 |
0.014 |
|
| 2015 |
Storr M, Weingart V, Arnstadt B, Allescher HD. DGE-BV Newsletter Endoskopie Heute. 28: 117-118. DOI: 10.1055/s-0034-1399300 |
0.013 |
|
| 2014 |
Brincat NA, Parker SC, Molinari M, Allen GC, Storr MT. Ab initio investigation of the uranium-oxygen system Plutonium Futures: the Science 2014. 133. |
0.012 |
|
| 2016 |
Storr M. [Healthy microbiome - healthy person?]. Mmw Fortschritte Der Medizin. 158: 42. PMID 27119695 DOI: 10.1007/s15006-016-7817-9 |
0.012 |
|
| 2017 |
Füeßl HS, Klose G, Labenz J, Storr M. Feiner Filter für die Informationsflut Gastro-News. 4: 3-3. DOI: 10.1007/s15036-017-0214-0 |
0.01 |
|
| 2016 |
Storr M. [In process]. Medizinische Monatsschrift Fur Pharmazeuten. 39: 391-5. PMID 29956514 |
0.01 |
|
| 2016 |
Storr M. [In Process Citation]. Medizinische Monatsschrift FüR Pharmazeuten. 39: 89-90. PMID 26983338 |
0.01 |
|
| 2015 |
Storr M. [In Process Citation]. Mmw Fortschritte Der Medizin. 157: 49. PMID 26953476 |
0.01 |
|
| 2015 |
Storr M. [In Process Citation]. Medizinische Monatsschrift FüR Pharmazeuten. 38: 413-4. PMID 26731860 |
0.01 |
|
| 2015 |
Storr M. [In Process Citation]. Mmw Fortschritte Der Medizin. 157: 39. PMID 26099400 DOI: 10.1007/s15006-015-3272-2 |
0.01 |
|
| 2015 |
Kubisch CH, Storr M. Obere gastrointestinale Blutung Mmw - Fortschritte Der Medizin. 157: 54-59. DOI: 10.1007/s15006-015-7544-7 |
0.01 |
|
| 2014 |
Storr M. [In Process Citation]. Medizinische Monatsschrift Fã¼R Pharmazeuten. 37: 78-9. PMID 24624612 |
0.01 |
|
| 2013 |
Storr M. [In Process Citation]. Medizinische Monatsschrift FüR Pharmazeuten. 36: 270-2. PMID 23898604 |
0.01 |
|
| 2012 |
Stewart E, Piteau S, Storr M, Mackenzie J, Hartsell A, Nagappan S. Index of suspicion. Pediatrics in Review / American Academy of Pediatrics. 33: 327-31. PMID 22753792 DOI: 10.1542/pir.33-7-327 |
0.01 |
|
| 2012 |
Boschetti-De-fierro A, Voigt M, Storr M, Krause B. A simple in vitro methodology for classifying dialysis membranes Procedia Engineering. 44: 730-732. DOI: 10.1016/j.proeng.2012.08.549 |
0.01 |
|
| 2011 |
Robinson M, Kenny SD, Smith R, Storr MT. Simulating radiation damage in Ga stabilised δ-Pu Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions With Materials and Atoms. 269: 2539-2548. DOI: 10.1016/j.nimb.2011.07.005 |
0.01 |
|
| 2009 |
Robinson M, Kenny SD, Smith R, Storr MT, McGee E. Simulating radiation damage in δ-plutonium Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions With Materials and Atoms. 267: 2967-2970. DOI: 10.1016/j.nimb.2009.06.113 |
0.01 |
|
| Hide low-probability matches. |